CA2305898A1 - Method for measuring tissue morphology - Google Patents
Method for measuring tissue morphology Download PDFInfo
- Publication number
- CA2305898A1 CA2305898A1 CA002305898A CA2305898A CA2305898A1 CA 2305898 A1 CA2305898 A1 CA 2305898A1 CA 002305898 A CA002305898 A CA 002305898A CA 2305898 A CA2305898 A CA 2305898A CA 2305898 A1 CA2305898 A1 CA 2305898A1
- Authority
- CA
- Canada
- Prior art keywords
- light
- tissue
- scattering
- probe
- nuclei
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims description 39
- 230000003287 optical effect Effects 0.000 claims abstract description 32
- 239000000835 fiber Substances 0.000 claims abstract description 21
- 239000000463 material Substances 0.000 claims abstract description 12
- 239000000523 sample Substances 0.000 claims description 42
- 238000001228 spectrum Methods 0.000 claims description 41
- 230000003595 spectral effect Effects 0.000 claims description 19
- 230000000737 periodic effect Effects 0.000 claims description 10
- 239000013307 optical fiber Substances 0.000 claims description 9
- 238000003384 imaging method Methods 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 3
- 230000005855 radiation Effects 0.000 abstract description 7
- 210000001519 tissue Anatomy 0.000 description 96
- 210000004940 nucleus Anatomy 0.000 description 29
- 238000010521 absorption reaction Methods 0.000 description 26
- 238000009826 distribution Methods 0.000 description 26
- 239000010410 layer Substances 0.000 description 22
- 210000004877 mucosa Anatomy 0.000 description 22
- 208000004804 Adenomatous Polyps Diseases 0.000 description 19
- 210000004027 cell Anatomy 0.000 description 18
- 210000000981 epithelium Anatomy 0.000 description 17
- 238000000985 reflectance spectrum Methods 0.000 description 17
- 238000013334 tissue model Methods 0.000 description 15
- 206010028980 Neoplasm Diseases 0.000 description 13
- 210000001072 colon Anatomy 0.000 description 13
- 238000001727 in vivo Methods 0.000 description 13
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 11
- 229910052760 oxygen Inorganic materials 0.000 description 11
- 239000001301 oxygen Substances 0.000 description 11
- 206010058314 Dysplasia Diseases 0.000 description 10
- 108010054147 Hemoglobins Proteins 0.000 description 10
- 102000001554 Hemoglobins Human genes 0.000 description 10
- 238000005259 measurement Methods 0.000 description 9
- 208000037062 Polyps Diseases 0.000 description 8
- 239000006096 absorbing agent Substances 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- 238000001574 biopsy Methods 0.000 description 8
- 210000004400 mucous membrane Anatomy 0.000 description 8
- 239000004793 Polystyrene Substances 0.000 description 7
- 201000011510 cancer Diseases 0.000 description 7
- 229920002223 polystyrene Polymers 0.000 description 7
- 108010035532 Collagen Proteins 0.000 description 6
- 102000008186 Collagen Human genes 0.000 description 6
- 229920001436 collagen Polymers 0.000 description 6
- 230000000875 corresponding effect Effects 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 6
- 210000003238 esophagus Anatomy 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 208000023514 Barrett esophagus Diseases 0.000 description 5
- 208000023665 Barrett oesophagus Diseases 0.000 description 5
- 239000011324 bead Substances 0.000 description 5
- 210000003855 cell nucleus Anatomy 0.000 description 5
- 238000007405 data analysis Methods 0.000 description 5
- 238000009792 diffusion process Methods 0.000 description 5
- 210000002919 epithelial cell Anatomy 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 108010064719 Oxyhemoglobins Proteins 0.000 description 4
- 238000000149 argon plasma sintering Methods 0.000 description 4
- 210000000805 cytoplasm Anatomy 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000001839 endoscopy Methods 0.000 description 4
- 210000005081 epithelial layer Anatomy 0.000 description 4
- 238000000386 microscopy Methods 0.000 description 4
- 239000002243 precursor Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 208000021096 adenomatous colon polyp Diseases 0.000 description 3
- 230000002238 attenuated effect Effects 0.000 description 3
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Inorganic materials [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 239000013553 cell monolayer Substances 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 210000002808 connective tissue Anatomy 0.000 description 3
- 238000013480 data collection Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 230000002895 hyperchromatic effect Effects 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000000877 morphologic effect Effects 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 2
- 230000008033 biological extinction Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000000112 colonic effect Effects 0.000 description 2
- 238000002052 colonoscopy Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 210000004177 elastic tissue Anatomy 0.000 description 2
- 238000002189 fluorescence spectrum Methods 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000001613 neoplastic effect Effects 0.000 description 2
- 238000010827 pathological analysis Methods 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 239000010453 quartz Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000004611 spectroscopical analysis Methods 0.000 description 2
- 239000002344 surface layer Substances 0.000 description 2
- 210000004876 tela submucosa Anatomy 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 229910052724 xenon Inorganic materials 0.000 description 2
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 2
- RNAMYOYQYRYFQY-UHFFFAOYSA-N 2-(4,4-difluoropiperidin-1-yl)-6-methoxy-n-(1-propan-2-ylpiperidin-4-yl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine Chemical compound N1=C(N2CCC(F)(F)CC2)N=C2C=C(OCCCN3CCCC3)C(OC)=CC2=C1NC1CCN(C(C)C)CC1 RNAMYOYQYRYFQY-UHFFFAOYSA-N 0.000 description 1
- INGWEZCOABYORO-UHFFFAOYSA-N 2-(furan-2-yl)-7-methyl-1h-1,8-naphthyridin-4-one Chemical compound N=1C2=NC(C)=CC=C2C(O)=CC=1C1=CC=CO1 INGWEZCOABYORO-UHFFFAOYSA-N 0.000 description 1
- 208000036764 Adenocarcinoma of the esophagus Diseases 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010071161 Colon dysplasia Diseases 0.000 description 1
- 208000002699 Digestive System Neoplasms Diseases 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 241000209035 Ilex Species 0.000 description 1
- 238000000342 Monte Carlo simulation Methods 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 238000001919 Rayleigh scattering spectroscopy Methods 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 238000004847 absorption spectroscopy Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 210000002777 columnar cell Anatomy 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 108010002255 deoxyhemoglobin Proteins 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 208000028653 esophageal adenocarcinoma Diseases 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000005350 fused silica glass Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000003278 haem Chemical group 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000013425 morphometry Methods 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 229910052705 radium Inorganic materials 0.000 description 1
- HCWPIIXVSYCSAN-UHFFFAOYSA-N radium atom Chemical compound [Ra] HCWPIIXVSYCSAN-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000001055 reflectance spectroscopy Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000003746 surface roughness Effects 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
- A61B5/0084—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
- A61B5/0084—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters
- A61B5/0086—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters using infrared radiation
Abstract
An apparatus for measuring one or more physical characteristics of material by means of optical radiation scattered by a tissue layer to determine, for example, the size of nuclei in a tissue layer. The apparatus includes fiber optic devices (10, 20, 30) to deliver and collect light from a tissue region of interest to determine, for example, whether the tissue is normal or precancerous.
Description
METHOD FOR MEASURING TISSUE MORPHOLOGY
GOVERNMENT SUPPORT
The invention was supported, in whole or in part, by a Grants No. P41RR02594 and CA53717 from the National Institutes For Health. The Government has certain rights in the invention.
RELATED APPLICATIONS
This is a continuation-in-part of U.S. Serial No.
08/948,734 filed on October 10, 1997, the entire contents of which is incorporated herein by reference.
BACKGROUND OF THE INVENTION
Methods for diagnosis of cancer at an early stage are essential for cancer prevention and therapy. Many types of cancers grow from epithelial tissues, which cover inner and SUBSTITUTE SHEET ( rute 26 ) outer surfaces of the human body. Many of these, for example cancer in gastrointestinal tract, progress through the stage of dysplasia. Dysplasia can be defined as neoplastic tissue which is not malignant yet, but is considered to be a precursor of malignancy. If diagnosed at this stage, most tumors are curable. In the case of gastrointestinal tumors, current methods of diagnosis are based on endoscopy. However, dysplastic tissue is frequently not endoscopically apparent. Thus, detection of dysplasia in the gastrointestinal tract and other sites often relies on sporadic sampling for this "invisible~~
malignant precursor. However, sporadic biopsies have a high probability of missing dysplastic changes. In some cases the biopsy procedure is impossible.
Efforts toward a substitution for standard biopsies have been made in order to provide accurate diagnosis of cancerous tissue in different organs in vivo and in real time. For this purpose, optical techniques that are non-invasive do not require tissue removal and can be performed in-vivo. Such methods provide information at the microscopic level and can thus provide for the search for very small sites which are likely to be missed by standard biopsies. While most human organs can be diagnosed by means of optical techniques, they are particularly applicable to the tissues in human body lumene, since they are easily accessible by optical probes, which can be SUBSTITUTE SHEET ( rule 26 ) inserted into one of the channels of a conventional endoscopic tube.
The present invention relates to the uae of light to determine physical characteristics of a structured layer of material, and in particular certain qualitative information regarding the morphology of tissue structures using scattered light. Both backscattered and transillumination methods can be used, depending upon the thickness of the material and the size and distribution of the structure being measured. Examples of properties of materials that can be measured include surface roughness, parasity, cytometer measurements, or any material in which changes in the refractive index of a material correspond to changes in structures. This type of scattering spectroscopy can be differentiated from absorption spectroscopy which is unable to quantitatively measure particle morphology.
Despite extensive investigations, no reliable optical technique to diagnose dysplasia in-vivo is known. One of the difficulties resides in the fact that dysplastic changes are limited to the uppermost epithelial layer, which can be as thin as 20um, a ane cell layer that is nearly transparent to optical radiation.
Tissue in the gastrointestinal tract, for example (other hollow organs share the same features also), is covered by a layer of cells called epithelium (from 20um SUBSTITUTE SHEET ( rude 26 ) to 300um thick depending on the part of the tract) supported by relatively acellular and highly vascular loose connective tissue, lamina propria, which can be up to 50oum in thickness and contains a network of collagen and elastic fibers, and variety of white blood cell types.
Beneath the lamina propria there is a muscular layer, muscularis mucosae, (up to 400um thick) and another layer of moderately dense connective tissue called submucosa (400-600um thick) containing many small blood vessels and abundant collagen and elastic fibers. The overall thickness of those layers is about lmm. Since a characteristic penetration depth of optical radiation into biological tissue does not usually exceed lmm, for a preferred embodiment it is sufficient to limit measurements of tissue by those layers.
Adenocarcinoma of the esophagus arises in metaplastic columnar epithelial cells in the esophagus, termed "Barrett's esophagus", which is a complication of long-standing gastrointestinal reflex. In this condition, the distal squamous epithelium is replaced by columnar epithelium consisting of a one cell layer which resembles that found in the intestines. Barrett's esophagus is frequently associated with dysplasia which later can progress to cancer. Trials of endoscopic surveillance of patients with Barrett's esophagus have not resulted in a reduction of esophageal cancer mortality. The most likely explanation is that dysplasia occurring 'in the esophagus SUBSTITUTE SHEET ( rule 26 cannot be seen with standard endoscopic imaging and sporadic biopsy sampling is necessary. This procedure can sample only about 0.3% of the tissue at risk. Thus, there is tremendous potential for sampling error.
The application of optical techniques to diagnose dysplasia in Barrett's esophagus is limited by the fact that the primary alterations in the tissue occur in the epithelium which is one cell thick (-20-30um) while fluorescence or reflectance spectra are mostly formed in deeper tissue layers. One of the most prominent features of a dysplastic epithelium is the presence of enlarged, hyperchromatic, and crowded nuclei. In fact, these changes ire nuclei size and spatial distribution are the main markers used by a pathologist to diagnose a tissue specimen as being dysplastic. No significant changes in other tissue layers is observed. Unfortunately, epithelium does not contain strong absorbers or fluorophores, and the thickness of the epithelium is relatively small and thus negligible. These make epithelium diagnosis in Barrett's esophagus to be a difficult problem.
Diffuse reflectance spectroscopy can provide quantitative biochemical and morphological information for the analysis of biological tissue epithelium and the detection of precancerous lesions. Diffuse reflectance spectra were collected from adenomatous colon polyps (cancer precursors) and normal colonic mucosa of patients undergoing colonoscopy. The data were analyzed using an SUBSTITUTE SHEET ( rule 26 ) WO 99/18845 PG"T/US98/21450 analytical light diffusion system, which was measured on a physical tissue model composed of polystyrene beads and hemoglobin. Four parameters were obtained: hemoglobin concentration, hemoglobin oxygen saturation, effective scatterer density, and effective scatterer size. Normal and adenomatous tissue sites exhibited differences in hemoglobin concentration and effective scatterer size.
Thus, diffuse reflectance can be used to obtain tissue biochemical and morphological information in vivo.
A preferred embodiment of the present invention relates to a system of measuring a fine structure component in backscattered light from mucosal tissue which is periodic in wavelength. This structure is ordinarily masked by a diffusive background, which must be removed to render it observable. The origin of this component is due to light which is Mie-scattered by surface epithelial cell nuclei. By analyzing the amplitude and frequency of the periodic structure, the density and size distribution of these nuclei can be extracted. These quantities are important indicators of neoplastic precancerous changes in biological tissue, and the technique can thus provide a useful tool for observing such changes in patients undergoing endoscopy.
The light that is incident on the thin layer at the tissue surface is not completely randomized. In this thin region the details of the elastic scattering process can be preserved. Mucosal tissues, which line the hollow organs SUBSTITUTE SHEET ( rule 26 ) of the body, generally consist of a thin surface layer of epithelial cells supported by underlying, relatively acelluiar connective tissue. In healthy tissues the epithelium often consists of a single, well-organized layer of cells with an endface diameter of about 10-20 a m and a height of about 25 a m. In cancerous and pre-cancerous (dysplastic) epithelium cells proliferate, the cellular layer often thickens and becomes more tightly packed, and the cell nuclei enlarge and appear darker (hyperchromatic) when stained. This may indicate increased nucleic acid density, hence increased refractive index.
A preferred embodiment of the invention utilizes a broadband light source to illuminate the region of interest in the tissue with optical radiation in the range between 350 and 700 nm. A fiber optic probe can be used to deliver and/or collect radiation from the tissue. The system can be used during endoscopy of a patient to optically survey a body lumen within the patient and thereby eliminate the need for removal~of tissue for biopsy, or alternatively, can be used to aid in locating tissue suitable for biopsy.
Backscattered light is preferably collected over a small collection angle of between 2° and 12°, preferably in the range between 3° and 8°. When using an optical fiber system to collect the scattered light fibers having a numerical aperture between 0.05 and 0.22, and preferably between 0.07 and 0.1 can be used. Collection angles within SUBSTITUTE SHEET ( rule 26 ) _g_ this range reduce the level of background light without loss of the periodic component in the returning light.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 is a schematic diagram of a fiber optic probe in accordance with the invention.
Figure 2 is an enlarged view of the distal end of an endoscope in accordance with the invention.
Figures 3A, 3B and 3C illustrate reflectance spectra from cell monolayers for normal colon cells (R - 0.46);
T84 cells (1t - 0.38);~(c) BaSO, diffusing plate (R - 1.0) Figure 4 illustrates nuclear size distributions from data of Figures 3A and 3B, respectively for normal colon cells; and T84 cells respectively. In each case, the solid line is the distribution extracted from the data, and the dashed line is the distribution measured using light microscopy.
Figures 5A, 5B and 5C are reflectance spectra from Barretts~ esophagus for diffuse reflectance from a normal site (solid line), a dysplastic site (dashed line), and the model fit (thick solid line); for corresponding fine structures; and of resulting nuclear size distributions, respectively.
Figure 6 graphically illustrates a comparison of samples analyzed by standard pathology and the optical methods in accordance with the invention.
SUBSTITUTE SHEET ( rule 2G
_g_ Figure 7 is a system used for in vitro tissue analysis in accordance with the invention.
Figure 8 is a process flow diagram illustrating a method of performing an optical diagnosis of tissue in accordance with the invention.
Figure 9 is the molar extinction coefficient spectra (per heme group) of the oxygenated (thin line0 and deoxygenated (thick line) hemoglobin (21). Note the characteristic peaks at 415, 542, and 577 nm {oxyhemoglobin-Hb02) and at 430 and 555 nm (deoxyhemoglobin-Hb).
Figure l0 is the reduced scattering cross section spectra Q' (1~), calculated using Mie theory. Results are shown for four different diameters, d" (0.2, 0.6, 1.0, and 2.0 ~cm). The slope of the spectra is inversely related to the diameter. A refractive index of 1.4 was assumed for the scattering particles, and 1.36 for the surrounding medium.
Figure 11 shows the Diffuse reflectance spectra measured on physical tissue models (thick line) corresponding to four different Hb concentrations: (a) 0.0 mg/dL, (b) 50 mg/dL, (c) 125 mg/dL, (d) 250 mg/dL. The analytical model predictions using the same optical parameters employed in the preparation of the physical tissue models are also shown (thin line), with agreement between the analytical and the tissue model being very good.
SUBSTITUTE SHEET ( ruie 26 ) Figure 12 shows the typical normal and adenomatous polyp spectra (thick line), and best fits to. the data using the model (thin line). Mie theory was used to approximate the reduced scattering coefficient used for the model fits (see Figure 13).
Figure 13 shows the scattering spectra obtained from the data shown in Figure 12 {thin line), and best fits using Mie theory (thick line). The Mie theory fits assign an effective scatterer size d$ to the reduced scattering spectra. The polyp is characterized by a larger effective scatterer size (ds = 1.5 um) as compared to normal mucosa ( d$ = 0 . 3 5 ~Cm) .
Figure 14A-14D show parameters obtained from data analysis: {A) total Hb concentration. Cue, (H) Hb oxygen saturation, a (C) effective scatterer density, pe, and (D) effective scatterer size, d,. The largest difference between normal mucosa (squares) and adenomatous polyps (stars) is observed in the total Hb concentration.
Figure 15 is a binary plot of the total Hb concentration Cue, vs. the effective scatterer size d9,. The normal data tend to form a well defined cluster, while the adenomatous polyp data are marked by wider variation.
The foregoing and other objects, features and advantages of the invention will be apparent from the following more particular description of preferred embodiments thereof, as illustrated in the accompanying drawings in which like reference characters refer to the SUBSTITUTE SHEET ( rule ZG ) WO 99/18845 PCT/US98lZ1450 same parts throughout the different views. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating the principles of the invention.
DETAILED DESCRIPTION OF THE INVENTION
A preferred embodiment of the invention involves the use of a fiber optic system to deliver and collect light from a region of interest to measure one or more physical characteristics of a surface layer. Such a system is illustrated in Figure 1. This system can include a light source 50 such as a broadband source, a fiber optic device 10 for delivery and/or collection of light from the tissue, a detector system 80 that detects the scattered light from the tissue, a computer 120 having a memory 122 that analyzes and stores the detected spectra, and a display 124 that displays the results of the measurement. A lens 60 can be used to couple light from the source 50 into the excitation fiber 30 of the probe 10. A filter 110 and lens system 90,100 can be used to efficiently couple collected light to a spectrograph 70. A controller 140 connected to the data processing system 120 can be connected to a clock and a pulser 150 that controls the light source 50.
The distal end 15 of the probe 10 is illustrated in Figure 2 where the central excitation fiber 30 is surrounded by six peripheral collection fiber 20. The distal end of the device can be enclosed in an optical shield 25 such as that described in U.S. Patent No.
SUBSTITUTE SHEET ( rule 2~ ) WO 99/18845 PGT/US98/~1450 5,199,431, the entire contents of which is incorporated herein by reference. Other endoscopic devices can be used such as an optical needle as described in the above referenced patent or as described in U.S. Patent No.
5,280,788, the entire contents of which is also incorporated herein by reference.
The collection fibers 20 preferably have a numerical aperture in the range of 0.05 to 0.22 in order to provide a desired collection angle from the material being measured.
This aids in reducing background that is removed from scattering spectrum without loss of the periodic component.
The collection fibers can also be replaced or supplemented by a distally mounted imaging sensor 35 such as a charged coupled device or CMOS imager. The sensor has a pixellated structure that is sensitive to the different colors contained in the scattering spectrum being recorded.
Further details regarding the use of a distally mounted sensor can be found in U.S. Serial No. 08/745,509 filed on November 12, 1996, the entire contents of which is incorporated herein by reference.
The backscattered light collected with this system can be analyzed to determine certain physical characteristics of epithelial tissue. The relationship between the collected light and the physical characteristics to be determined using this light can be described as follows.
Epithelial nuclei can be represented as spheroidal Mie scatterers with a refractive index higher than that of the SUBSTITUTE SHEET ( ruie 26 ) wo ~nssas pcrn,rs9sniaso surrounding cytoplasm. Normal nuclei have a characteristic diameter 1=4-7um. In contrast, dysplastic nuclei can be as large as 20 u~a in size, occupying almost the entire cell volume. Thus, in the visible range, the wavelength h « I, and the component of light scattered by the nuclei will exhibit a periodicity with wavelength, the details of which are determined by the nuclear size distribution. The Van de~Hulst approximation can be used to describe the optical scattering cross section of the nuclei:
~f(~,,1) - 1 ~lZ 1 _ sin(28W) + sin(a W) 2 ~ ( 1 2 ~I~, ~I~.
where 8= ~rln~(n-1) , with n~ the refractive index of cytoplasm and n the refractive index of the nuclei relative to that of cytoplasm.
When a beam of light is incident on an epithelial layer of tissue, a portion of this light is backscattered from the epithelial nuclei, while the remainder is transmitted to deeper tissue layers, where it undergoes multiple scattering and becomes randomized. All of the diffusive light which is not absorbed in the tissue eventually returns to the surface, passing once more through the epithelium, where it is again subject to scattering from the cell nuclei. Thus, the emerging light consists of a large diffusive background plus the component of forward scattered and backscattered light from the nuclei in the epithelial layer. For a thin slab of SUBSTITUTE SHEET ( rule 2G ) WO 99/1$845 PCTIUS98I21450 epithelial tissue containing nuclei with size distribution N(I) (number of nuclei per unit area (mm~) and per unit interval of nuclear diameter (um)), the approximate solution of the transport equation for the reflectance R(1~) collected by an optical probe with acceptance solid angle SZ~ is given by the following expression:
R(~,} a rt~~ + 1 1 ~, ~~l) \le~~'' s~~p~~''s' s~~~nr +\Id ~~''s,~z ~~n~ ( 2 ) d ( ~ ~flo where Ii ( tl~. s> ) is the intensity of the incident light delivered in solid angle 52;, Id(~,,s) is the intensity of the light emerging from the underlying tissue, and (1(s)~f~= jt(s)ds for any function I (s) and solid angel ~2, n with s a unit vector pointing outward from the tissue surface in an arbitrary direction. The quantity R(~,) =~Id(~,,s)~n~ I ~l,(~.,s)~~~ is the reflectance of the diffusive background. The optical distance W
z(~,) _ ~Qs(~.,1)N{1)dl and scattering phase function p(~,,s,s')= 1 jp(~,,l,s,s')Crf(~,,1)N(I)dl both depend on N(1) ; for a To sphere, p(~,,l,s,s') is determined by Mie theory. The first term in Eq. (2) describes the attenuation of the diffusive SUBSTITUTE SHEET ( rule 2b ) background, and the terms in brackets describe backscattering of the incident light and forward scattering of diffusive background by the epithelial cell nuclei, respectively.
For small S'2~ the forward scattering term in Eq. (2) can be expanded in T ( 1~) . Thus, ~~Id(~.,s ~~=x~ . l ~Id(~,,s)~o~ a fo + f,r l r,, O.
with zo =~rl2JlZN(l~dl. It is found numerically that fl«fa and that fo and fl are approximately independent of wavelength in the range of interest (~,~;o = 360 to ~,~u = 685nm). Similarly, for the backscattering term ~~I~(.~,-s)p~~.'s s~~~n,~n' l~Id(~,'s)~n~ =bo-b, r/ro. Note that in the forward scattering contribution the first order term oscillates in phase with r(~,~ as required by the optical theorem, whereas for the backscattering contribution it is out of phase. Thus, Eq. (2) reduces to R~~) = a s~'~~ + (1- a '~s~ l~ + bo ~" (.f -b~ ) ~~~) , R (~) zo (~) which shows that the epithelial nuclei introduce a periodic fine structure component into the reflectance with a wavelength dependence similar to that of the corresponding scattering cross section. Its periodicity is approximately proportional to nuclear diameter, and its amplitude is a SUBSTITUTE SHEET ( rule 26 ) function of the size and number of nuclei in the epithelial layer. These quantities can be determined by analyzing the reflectance, R (1~) .
As example of the effects described by Eq. (2), elastic light scattering from normal T84 tumor human colonic cell monolayers (10 and 15 sites respectively) was measured and analyzed. The cells, approximately l5um long, were affixed to glass slides in buffer solution and placed on top of a BaS04 diffusing (and highly reflective) plate. The BaSO, plate was used to approximate the diffuse reflectance from underlying tissue. The diameters of the normal cell nuclei generally ranged from 5 to 7 um and those of the tumor cells from 7 to l6y,m.
An optical fiber probe was used to deliver white light from a xenon arc flashlamp to the samples and collect the return reflectance signal, as shown in Figure 1. The probe tip, 1 mrn in diameter, consisted of a central delivery fiber surrounded by six collection fibers, all of which were covered with a 1 mm thick quartz optical shield. The fibers were 200 urn core fused silica, NA=0.22 ~5~~=S2~=~dVA2~. To eliminate specular reflection, the probe was beveled at 17° to the normal. At the proximal end the collection fibers were arranged in a line and imaged onto the input slit of a spectrograph. A diode array detector recorded the reflectance spectra from 360 to 685 nm.
SUBSTITUTE SHEET ( rule 26 Figures 3A and 38 show the normalized reflectance R (1.) / rt'(?~) from normal and T84 tumor cell samples, respectively. Distinct spectral features are apparent.
For comparison, the reflectance spectrum from the BaS04 plate by itself is also shown in Figure 3C. This spectrum lacks structure and shows no prominent features.
To obtain information about the nuclear size distribution from the reflectance data, Eq.(3) needs to be inverted. The nuclear size distribution, N(1), can then be obtained from the Fourier transform of the periodic component of the opt ical distance z - zo = (I - R(~,)~ / q. The parameter q = 1 - bo - fo +2 (bl - fl) is associated with forward and backward scattering, and depends on the probe geometry and the angular distribution of the incident and reflected light. In this particular example q=0.15. By introducing the effective wavenumber k=2lla~ (n-1) /~,-ko , and ko =2ms~(n-1)l ~,",~,K=2nre~(n-1)~~,n;;" -~,-";~~ and we obtain, K
N(1} = q~ 2 f R~~~ -1 e~ (k + ko )dk. ( 4 ) Equation (4) was used to analyze the data. In order to remove spurious oscillations, N(1) was further processed by convolving it with a Gaussian filtering function. The solid curves in Figure 4 show the resulting SUBSTITUTE SHEET ( ruie 26 ) nuclear size distributions of the normal and T84 cell monolayer samples extracted from the spectra of Figures 3A
and 3B. A nucleus-to-cytoplasm relative refractive index of n=1.06 and cytoplasm refractive index of n~=1.36 were used. The dashed curves show the corresponding size distributions, measured morphometrically via light microscopy. The size distributions can be approximated by Gaussian distributions. The parameters for those are presented in Table 1. The extracted and measured distributions are in good agreement for both normal and T84 cell samples.
Normal Cells Tumor T84 Cells Mean Standard Mean Standard Diameter Deviation Diameter Deviation (gym) (~Cm) (gym) (!gym) Microscopy -.6 ~0.5 10.2 2.0 Spectroscopy6.2 0.45 10.1 2.2 The periodic fine structure in diffuse reflectance of esophagus and colon mucosa of human subjects can be measured during gastroenterological endoscopy procedures.
In the case of Harretts' esophagus, in which the epithelium consists of a thin monolayer of columnar cells. similar to those used in the cell culture experiments, data were collected as in the cell culture studies. The optical fiber probe is inserted into the biopsy channel of the endoscope and brought into contact with the tissue surface.
SUBSTITUTE SHEET ( ruie 26 ) WO 99/18845 PGTlUS98/21450 The methods described herein can also be used to measure structural properties of other GI tissue, tissues in the oral cavity, the cervix, the bladder, and skin.
The fine structure component, which is the scattering signature of the cell nuclei, is typically less then 5% of the total signal and is ordinarily masked by the background of diffusely scattered light from underlying tissue, which itself exhibits spectral features due to absorption and scattering, as shown in Figure 5A. Its spectral features are dominated by the characteristic absorption bands of hemoglobin and collagen scattering. In order to observe the fine structure, this background must be removed. The absorption length, ~Q', ranges from 0.5 to 250 mm as the wavelength is varied, and the effective scattering length (~,,')-1 ranges from 0.1 to 1 mm. Thus, both scattering and absorption have to be taken into account in subtracting or removing the background signal.
To represent the background light incident on the tissue is assumed to be exponentially attenuated, and that at any given depth, z, an amount of light proportional to the reduced scattering coefficient ,uQ is scattered back towards the surface and further exponentially attenuated.
Since light attenuation depends on both scattering and absorption, the attenuation coefficient is assumed to be the sum of absorption coefficient a and effective a scattering coefficient ~.,~°~=~i~u,' . The parameter (3 was SUBSTITUTE SHEET ( ruie 26 ) wo ~nss4s Pcnus9ani4so determined by comparison with Monte Carlo simulations and more accurate models of light transport, and was found to be p~0.0'7. Since light only penetrates ~1 mm into the tissue, most of the diffusely scattered return light is confined to the mucosal layer.
The tissue is thereby represented as a two layer medium and neglected diffusely reflected light from the Lower layer. The following approximate expression for the diffusive light from underlying tissue impinging on the epithelial cell layer is then obtained:
_ _ c~~
la('~~s) = F'(S)~Ir(~~s~nr 1 expf (fps +~~f~a)~J (5) 1 + c( fta I acs ) with F(s) being a Lambertian function describing the angular dependence of light emerging from mucosal layer, L
a parameter representing the thickness of the mucosal layer, and L a parameter representing the thickness of the mucosal layer, and c, the concentration of hemoglobin, which we find to be the main absorber relative to that of collagen, which is responsible for light scattering.
Because both oxygenated and deoxygenated hemoglobin are present, the total hemoglobin absorption is represented as ,uQ=(I-a)~t~~~+afto'~°~~ with oxygen saturation parameter a(0 <_ a S 1).
Figure 5A shows the reflectance spectra from two Barretts~ esophagus tissue sites, both independently SUBSTITUTE SHEET ( rule 2G ) diagnosed by standard pathological analysis to indicate (1) normal and (2) precancerous (i.e. low grade dysplasia). As can be seen, the differences in these unprocessed spectra are small. To analyze them, Eq.(5.) was first fit to the broad features of the data by varying the parameters c, a and L. As seen in Figure 5A, the resulting fits are quite accurate. After removing this diffuse background structure by calculating R(A)/R(a), the periodic fine structure is seen in Figure 5B. Note that the fine structure from the dysplastic tissue site exhibits higher frequency content than that from the normal site. Equation (4) was then employed to extract the respective nuclear size distributions, yielding Figure 5C. The difference between normal and dysplastic tissue sites is evident. The distribution of nuclei from the dysplastic site is much broader than that from the normal site and the peak diameter is shifted from -.7 ~m to about -.10 um. In addition, both the relative number of large nuclei (>l0um) and the total number of nuclei are significantly increased.
Based on computer analysis, the uncertainty of the above method in extracting nuclear size information is estimated to be from 5% to 30%, depending on the noise level and accuracy of the model. The distributions were calculated using the same refractive index for both normal and dysplastic nuclei. This is not entirely correct, inasmuch as in stained histological sections dysplastic nuclei appear hyperchromatic, which maybe indicative of an SUBSTITUTE SHEET ( rule 26 ) WO 99/18845 PCT/US98l21450 increase in refractive index. Thus, the relative number of large nuclei in the distributions measured from dysplastic sites may be slightly overestimated.
The ability to measure nuclear size distribution in vivo has valuable applications in clinical medicine.
Enlarged nuclei are primary indicators of cancer, dysplasia and cell regeneration. In addition, measurement of nuclei of different size can provide information about the presence of particular cells, and can thus serve, for example, as an indicator of inflammatory response of biological tissue. This suggests that different morphology/pathology in the mucosal Iayer gives rise to distinct patterns of nuclear distributions.
The physical characteristics that have been found to be useful to differentiate between Barrett's non-dysplastic and dysplastic epithelium were the total number of nuclei and the percentage of large nuclei ( I > 10 u~). A
comparison of pathological analysis of samples with the optical analysis thereof provided the plot (total number of nuclei vs. percentage of nuclei with a diameter large that 10 um) in Figure 6. From those 50 sites, the cumulative sensitivity and specificity, for this analysis were 83% and 100% respectively. The study had a positive predictive value is 100%. The points indicated by n's were either normal or inflamed and those indicated by d's were displastic. A percentage in the range of 20-30% was found SUBSTITUTE SHEET ( rule 26 ) WO 99/18845 PCTIUS98I~1450 to be an accurate diagnostic for this type, with 25% being used in this particular example.
A preferred embodiment of a spectrograph system 300 employed for the collection of backscattered spectral data from excised tissue samples using a spectrograph and a charge coupled device (CCD), CMOS or other integrated solid state imaging array is illustrated in Figure 7.
System 300 can use a broadband light source or tunable laser 314 for irradiating a sample 46. Source 314 generates a beam 316 which is directed by mirror 318 through focusing optics 320 to impinge on sample 46 mounted on a scattering substrate 325 and behind a transparent window 321. The beam was focused on the sample at an angle of incidence. The collection angle 330 can be determined by an aperture or collimator 340 and is between 2 and 12 degrees, preferably between 3 and 8 degrees.
A portion of the scattered light 322 emitted by sample 46 was collected by collecting optics 324 a small angle relative to the incident light. In another preferred embodiment the angle of incidence and collection can be along a single common axis. Collecting optics 324 collimates and F/matches the collected light for the spectrograph 310. Prior to entering the entrance slit of the spectrograph 310, the collected light was passed through a series of filters 326 which attenuated the unwanted scattered component of the collected light.
SUBSTITUTE SHEET ( rule 25 ) WO 99/1$845 PCTIUS98IZ1450 Figure 8 illustrates generally a process 400 for collecting and analyzing the scattering spectrum from a material of interest such as tissue. The method can be performed both is vitro using a microscopy system or a color imaging system as shown in Figure 7, or in vi vo on a patient. The illuminating light 402 from a source can use radiation in the range of 300nm-1200nm, including the infrared range. After collecting 404 and detecting 406 radiation, the diffuse background 408 can be removed and the desired characteristics calculated 410. These results can be used to provide a diagnosis of the region of interest.
A preferred embodiment of the present invention employs an analytical method based on data collection with an optical fiber probe with fixed delivery and collection geometry. Data analysis uses light diffusion, but rather than directly apply the model to analyze tissue spectra, a correspondence is established between the diffuse reflectance spectra and a physical tissue representation composed of scatterers and absorbers with known optical properties. By analyzing spectra from this tissue model using the analytical formulation, a calibration system is provided which is simple to invert and accurately predicts the concentrations of the scatterers and absorbers. Once the calibration is established, the method is applied to tissue spectra.
SUBSTITUTE SHEET ( ruie 26 ) The following relates to the application of spectral analysis to mucosal surfaces of tissues in vivo. In this example adenomatous colon polyps are measured, which are precursors of colon cancer. These polyps are a form of colonic dysplasia and are histologically similar to visually undetectable flat dysplasia, and are readily detectable. The results are correlated with standard histological examination, and can be used for early detection of disease and, moat importantly, exemplify how this spectroscopic method can be applied in vivo to obtain morphological and biochemical information.
Diffuse reflectance spectra were collected in vivo from adenomatous polyps on 13 patients undergoing routine colonoscopy. Data were collected simultaneously with multi-excitation fluorescence spectra: a xenon-arc flashlamp with 10 acs pulse duration and an average input energy of 4Jj/pulse was used as white light source. An imaging spectrograph dispersed the collected, light and a gated diode array detector was employed for light detection in the 360-685 nm spectral range. A 12 ,sec gate synchronized with the lamp pulse was used to minimize background from endoscopic illumination. The detector was controlled by a PC notebook computer, where the data were transferred and stored.
Light was delivered and collected using an optical fiber probe which was advanced through the accessory channel of the colonoscope and brought into contact with SUBSTITUTE SHEET ( rule 26 ) WO 99/18845 PGTIUS98l21450 the tissue. The probe consisted of a central optical fiber for light delivery, surrounded by six concentric fibers for light collection. All fibers had 200 ~cm core diameter and NA=0.22. The probe tip was fitted with a quartz shield approximately 1.5 mm in length and diameter, which provided a fixed delivery/collection geometry with uniform circular delivery and collection spots in the form of overlapping cones with approximate radii of rd=0.35 mm and r~=0.55 mm, respectively. The tip was beveled at an angle of 17 degrees, to eliminate unwanted specular reflections from the shield/air interface.
The diffuse reflectance spectrum of a 20% by volume BaS04 powder suspension was used as a reference, to take into account the spectral characteristics and overall intensity of the xenon lamp. The probe was immersed in the suspension and a reference diffuse reflectance spectrum was recorded prior to collection of each data set. Tissue spectra were calibrated by dividing by this reference spectrum. Diffuse reflectance spectra were measured from a few different sites on every adenomatous polyp and from corresponding sites in the surrounding normal mucosa.
Single-pulse excitation was used in order to avoid motional artifacts. The polyps were than removed and examined histologically, while the normal mucosa sites were not biopsied.
To represent diffuse reflectance, biological tissue was approximated as being a homogeneous semi-infinite SUBSTITUTE SHEET ( rule 26 ) turbid medium with reduced scattering and absorption coefficients ~,,' (A) and ~Ca' (1~) , respectively (?~ is the wavelength of light). Part of the incident light is absorbed in the tissue, while the non-absorbed part is subject to multiple scattering and eventually emerges from the surface as diffuse reflectance. A certain fraction of this return light is collected by the probe, while the remaining part escapes undetected. The amount of the light collected depends on the optical properties ~c9' (a) and ~.
(h), as well as on the probe diameter, rp. Because r~ is finite, it serves as a scale length, enabling ice' (1~) and ' (1~) to be determined separately.
To characterize light collection by an optical probe, knowledge of the spatial and angular resolution of the diffuse reflectance on the surface of the tissue is required. Using the method of images to implement the diffusion approximation to the radiative transfer equation the diffuse reflectance radial density, R (1~, r), at a distance r from the point of incidence of the light on the surface of a semi-infinite turbid medium is given by ~~~~r~=4~ of~s (~+~)e~~~~ _(1+3A)(f~+r )er~ ~ (6) s ~r 1 1 z z Ilz where ~ _ (3,uQ (f~a - fps )) ~ zo , ~s +~a and r, =(zo +rz~'n,r2 -Czo(1+ 3 A)z +rzJ
SUBSTITUTE SHEET ( rule 26 ) The parameter A depends on the refractive index n of the medium (A=1 for n=1 and A>1 for n>1). A reasonable assumption for the average refractive index of colon tissue is n~ 1.4 so that A ~ 3.2.
To find the total light collected by the probe, Eq. 6 must be integrated over the spatial extend of the delivery and collection areas, characterized by radii rd and r~, respectively. Assuming the incident light intensity to be uniform over the entire delivery area, the diffuse reflectance Rp (2~) collected by the probe is given by r yx r Rp(~.)= ~ ~rdrld~~R(~.,r-r)rdr~ r ('1) with ~ r - r'~ _ ~rz + r2 - 2rr' cos~)~~j . The integral s i s Eq . 7 can be evaluated numerically. However, to obtain a simple analytical expression for R.~ (A), we assume point delivery of light (rd = 0) and collection over a circular spot of radium r~, we then obtain:
r Rp(~.) = 2~~ R(r)rdr SUBSTITUTE SHEET ( rule 26 ) -(1+1~~~° e-d.~ 4 e-~i - ~s e-'"° xe l 3 -za ; -(1+-A)za , (8) ,us +,uQ r~ 3 r2 i/2 2 Z l/2 , l with r2 =(zo +r~ ) ,r~ = zo~l+ 3 AJ +r~
The optimal value of r~ was found by calibrating Eq. 8 on physical tissue models with known optical properties. The S advantage of using Eq. 8 is that it is much easier to invert than Eg. 7, which requires numerical integration.
Eq. 8 gives the diffuse reflectance at the perpendicular direction to the tissue surface. This is acceptable because light is only collected by the optical probe at directions with a maximum deviation of approximately 10 degrees from the direction perpendicular to the surface.
Eq. a can be used to analyze the diffuse reflectance spectra collected by the probe. From these measurements of the tissue spectra, hemoglobin is the only significant light absorber in colon tissue in the visible range of the spectrum, and is encountered in both oxygenated and deoxygenated forms. The light absorption properties of both forms have been studied and their molar extinction coefficient spectra E~2 (A) , e~, (1~) are shown in Figure 9.
Oxyhemoglobin absorption presents a maximum at 415 nm and two secondary maxima at 542 and 577 nm, while deoxyhemoglobin has a maximum at 430 nm and only one SUBSTITUTE SHEET ( rule 26 ) WO 99118845 PG"fIUS98/Z1450 secondary maximum at 555 nm. The total absorption coefficient, ~Cj (A) is given by f~Y~'~~=2.3Chb~asbbo,~'~)+(1-a~E~b~'~)) , (9) where a = C'~°= is the Hb oxygen saturation parameter, ChbO~ + Chb S CbbO~and C~ are the concentrations of oxy and deoxy Hb, respectively, and C~b - Cb~z + C~ the total concentration o f HB .
Determination of Cue, and a was performed in the following way. For a given tissue spectrum, R.p(1~), initial values were assigned (typically C~ = 0.0 and a = 0.5).
Eq. 8 was then numerically inverted to find ~s' (1~), which exhibited residual spectral features of HB absorption. The parameters C,~ and a were then modified, and the process was repeated recursively until ~.S' (1~) exhibited a smooth spectral shape with the Hb spectral features absent. In this way, ~.,' (A) was simultaneously determined with Cue, and a.
Table 2 Model Normal Adenomatous Parameter Polyp SUBSTITUTE SHEET ( rule 26 Total Hb Concentration C~ (mg/dL) 13.6 t 72.0 29.2 a.s Hb Oxygen Saturation 0.59 ~ 0.63 0.10 a 0.08 Effective Scatterer Density 9.2 ~ 3.5 4.0 ps (xl0e mm-3) 7.5 Effective Scatterer Size 0.56 ~ 0.94 0.44 de (mm) 0.18 The above procedure is based on the assumption that ,g' (?,.) is a relatively smooth function of the wavelength A, which analysis confirms, as will become evident from the discussion below. In general, ~Ca' (1~) is the sum of contributions from the various tissue scatterers.
Unfortunately, detailed information about these individual scatterers is not available . Therefore, ~,e' (1~) was written as f~s~'~~ = Ps~~~~~~ ( 10 ) SUBSTITUTE SHEET ( rule 26 ) with p, the effective scattering density and o' (h) the effective reduced scattering cross section, i.e, the tissue scattering properties are modeled in an average way, as if tissue contained a single well-defined type of scatterer.
In general, a' (1~) depends on the refractive index, shape and size of the scatterer, as well as on the refractive index of the surrounding medium. For a spherical scatterer with diameter d8, o' (1~) can be calculated numerically using Mie scattering theory.
Figure 10 shows such a calculation of a' (1~)., Note that the slope of Q.' (J~) depends on ds in a simple way i . a .
the slope is inversely related to scatterer size. In this way it was possible to assign a scatterer size to every a' (?~) and hence to every ~.a' (J~) in the range ds = 0.2-2.0 um. For example, by inspecting ~.,' (1~) of normal colon mucosa, previously reported based on in vitro measurements, it can be seen that they correspond to a scatterer size d$
0.35 ~Cm. Once da was determined, the density p~ was by dividing ~B' (1~) by Q' (h) . In summary, for each tissue diffuse reflectance spectrum four parameters were obtained, Cue" a , p~ and d9 .
In calculating the results shown in Figure 10, the scatterer and the surrounding medium refractive indices were assumed similar to those likely to be found in tissue.
Reasonable approximations are a refractive index of approximately 1.4 for the scatterers and 1.36 for the surrounding medium. These values can be justified by SUBSTITUTE SHEET ( rule 26 noting that the lower bound for the tissue refractive index is set by the refractive index of water, which is approximately equal to 1.33 in the visible range, and the upper bound is set by the maximum refractive index reported for soft tissue, which is around 1.45. Such values are consistent with those generally observed for soft biological tissues.
The physical tissue representation served as a method for confirming the applicability of the various approximations made in developing Eq. 8. The samples consisted of mixtures of spherical microparticles with Hb in various concentrations. The model established that these mixtures simulated the optical properties of tissue samples. In addition, the range of validity of the analytical model in terms of the optical properties was established, and the optimal value for the parameter r~, Eq. 8. was determined.
Polystyrene bead suspensions in de-ionized water (Polysciences, Inc.) were used to simulate tissue light scattering, and Hb solutions prepared from lyophilized human Hb (Sigma, H0267) were used to stimulate absorption.
The scattering properties of the beads were calculated using Mie theory. The bead diameter was 1.07 ~Cm, and the refractive index np of polystyrene was given by the expression of np = 15607 + 10002/ 1~~ (26) , (A in nm) , and the polystyrene concentration was 0.625 by volume. The reduced scattering coefficient varied from approximately SUBSTITUTE SHEET ( ruie 26 ) WO 99118845 PC'f/US98I21450 1.7 mm-1 at 400 nm. This spectral dependence is similar to that shown in Figure 10 with dA = 1.0 ~cm, with the difference that the slope is larger due to the larger refractive index of polystyrene.
Since light absorption by polystyrene is negligible in the visible range, absorption was solely due to oxyhemoglobin. The size of the physical-tissue model was approximately 3x3x0.5 cm, simulating the flat geometry of normal colon mucosa. Additional geometries were investigated such as a cylindrical geometry with 1 cm depth and 0.5 cm diameter, to simulate the geometry of the polyps, but no significant spectral differences were found.
The range of optical parameters used was chosen based on the previously reported independent measurements of colon tissue optical parameters performed in vitro.
Figure 11 shows diffuse reflectance spectra measured on the physical tissue model with various concentrations of Hb vs. the analytical model predictions, which were obtained by setting r~ = 0.45 mm in Eq. 3. This was determined to be the optimal value for r~, which was kept fixed throughout the entire data analysis. It was also found that the parameter Zo = 1/ (0. 6~d + ~,,' ) improved the agreement between the analytical model and the. physical tissue model data, especially for large values of absorption. The physical tissue model spectra shown in Figure lI are very similar to the tissue spectra presented below. This fact serves as indirect confirmation of the SUBSTITUTE SHEET ( rule 26 ) wo ~n~s PCTIUS98121450 assumptions made in developing the model, regarding tissue scatterers (modeled as microspheres) and tissue absorption (attributed to Hb).
The analytical model was found to accurately predict the physical tissue model spectra for Hb concentrations in the physiological range of interest. For Hb concentrations lower than 100 mg/dL, the deviation betv~ieen the two models was always smaller than 10% over the entire wavelength range. The largest deviation occurred when absorption became comparable to scattering. This is shown in curve (d) of Figure ll, near the peak of Hb absorption, around 415 nm. The Hb concentration was in this case 250 mg/dL
which corresponds to an absorption coefficient of approximately 5 mm-1 at 415 nm, while the scattering coefficient was approximately 2.8 mm-1 at the same wavelength.
Figure 12 shows typical diffuse reflectance spectra from one adenomatous polyp site and one normal mucosa site.
Significant spectral differences are readily observable, especially in the blue region of the spectrum, where the Hb absorption valley around 420 nm is the prominent spectral feature. This valley is much more prominent int he polyp spectrum, which also shows a continuous decrease in intensity starting from the red end (-700 nm) and moving toward the green region (--500 nm) of the spectrum, while in the same range the normal mucosa spectrum shows a steady increase in intensity. The secondary absorption dips of SUBSTITUTE SHEET ( rule 26 ) wo ~nss4s rrr~s9sm4so oxyhemoglobin (542 and 577 nm) are much more prominent in the adenomatous polyp spectrum, indicating increased Hb concentration. According to the model analysis the normal mucosa spectrum was characterized by Hb concentration C,~, _ 22.5 mg/dL, while the corresponding value for the adenomatous polyp was about 6 times higher (C~ = 165 mg/dL). The Hb saturation was found to be 0.65 t 0.05, and 0.55 ~ 0.05 respectively.
Figure 13 shows the scattering spectra ~.$' (h) calculated from the data shown in Figure 12, along with the best Mie theory fits. The main difference between the spectra of the two tissue types is observed in the spectral slope, which corresponds to different effective scattering sizes, de = 1.5 ~,m for the polyp and de = 0.35 ~,m for normal mucosa. The values for the scatterer densities were found to be pa = 1:5x108 mm-' for the normal mucosa, and pe =
1.3x108 mm-3 for the adenomatous polyp. Figure 12 also shows the best analytical model fits to the data, using Eq.
8. The model accurately describes the data, despite the dramatic differences noted in the spectral shape between the two tissue types and the fact that GCB' (A) is approximated assuming a homogeneous distribution of spherical scatterers. The deviation between the data and the model in typically smaller than 10~ for most of the wavelength range.
Figures 14A-14D shows the calculated values of the four parameters for all tissue sites studied: (A) total Hb SUBSTITUTE SHEET ( ruie 26 ) WO 99118845 PCTlUS98l11450 concentration C,~ (B) Hb oxygen saturation a, (C) effective scatterer density p, and (D) effectiveness scatterer size d,. Adenomatous polyps were clearly characterized by increased Hb concentration, while there were no observable differences in terms of the Hb oxygen saturation. The effective scatterer density was in general lower in adenomatous polyps, and the effective scatterer size larger, even though there was significant overlap of these parameter distributions between the two tissue types.
Table 2 summarizes the results shown in Figures 14A-14D by giving the average values and the standard deviations for each parameter.
Figure 15 shows a plot of the Hb concentration C,~, vs. the effective scatterer size de. These two parameters are shown together in order to summarize and illustrate the differences found in the scattering and absorption properties of normal mucosa and adenomatous polyps in the colon. Note that the normal mucosa data tend to form a cluster, while the adenomatous polyp data are separated, and characterized by a wider spread and irregular distribution, in both the effective scatterer size and the Hb concentration.
A methodology has been described which provides quantitative information about colon mucosal tissues in vivo, based on diffuse reflectance measurements. The main components of this methodology are (a) data collection through an optical fiber probe with a fixed SUBSTITUTE SHEET ( ruie 2G ) wo ~ns84s rcrn.rs9sni4so delivery/collection geometry, (b) an analytical model for data analysis based on light diffusion, and (c) a physical tissue model for calibration of the analytical model.
The use of an optical probe with fixed geometry enables consistent data collection, and independent determination of the scattering and absorption. Modeling of the probe geometry is facilitated through the use of the parameter r~, which also defined the probe s sensitivity to absorption. A probe with large r~ will render the spectra collected more sensitive to tissue absorption as compared to a probe with a smaller r~. In Figure 4, the secondary Hb absorption peaks are barely noticeable in the normal mucosa spectrum: a probe with larger r~ would make these features more prominent.
The analytical diffusion theory model is amenable to numerical inversion and successfully describes the tissue data after calibration on the physical tissuemodel composed of polystyrene beads and oxy hemoglobin. Other researchers have already used variants of the analytical model described here, in the study of diffuse reflectance from tissues and physical tissue models in the IR range. The present study is, to our knowledge, the first to apply the model in the visible range, to in vivo data from human mucosal tissue, measured with an optical fiber probe. By working in the visible rather than in the IR, light penetration was restricted to approximately 0.5 mm, i.e.
the mucosa layer where precancerous changes occur. Using SUBSTITUTE SHEET ( ruie 26 ) the model, we have shown that it is possible to obtain quantitative information about the tissue studied, such as Hb concentration, Hb oxygen saturation, effective scatterer size, and effective scatterer density. The results show that diffuse reflectance provides a tool for quantitative analysis of mucosal tissue surfaces in vivo.
' The basic approximation made in the model is that Hb is the only significant absorber in colon mucosa in the visible range of the spectrum. Even though this assumption IO lacks direct confirmation, the fact that the data strongly exhibit the characteristic features of Hb absorption, clearly indicates that Hb is a major absorber. In addition, the spectra measured on the tissue physical model, in which Hb was the only absorber, closely resemble the tissue spectra.
In a similar way, tissue scattering was modeled as due to homogeneous spherical scatterers with known refractive index. The approximation permits a quantitative characterization in terms of two basic parameters, the effective scatterer size and the effective scatterer density. Theae parameters provide an estimate of the average scattering properties. The fact that the spectra measured on physical tissue models reproduce the actual tissue spectra, serves again (as in the case of Hb), as an indirect confirmation of the validity of this approximation.
SUBSTITUTE SHEET ( rule 26 ) Data analysis showed that adenomatous colon polyps were characterized by increased Hb concentration. It is known that tumors and cancerous tissues exhibit increased microvasculature, and hence increased blood content. Using morphometry and vascular casting in combination with scanning electron microscopy techniques. Precancerous tissues such as adenomatous polyps of the colon are also characterized by increased microvascular volume the above in agreement with these reports in terms of observing the IO increased Hb concentration. Others report increased microvascularity of the colon mucosa associated with Crohn~s disease and ulcerative colitis. Even though we did not study these tissue types, the technique employed here could prove useful for the in vivo study of such diseases.
The Hb oxygen saturation was found to be approximately 60%, on average, for both normal mucosa and adenomatous polyps. This result is reasonable, because the measurements were essentially performed in the capillary network of the mucosa, where oxygen is transferred from Hb to tissue. Hb oxygen saturation drops within the capillaries from approximately 97% (arterial blood) to about 40% (venous blood) with the measured values (around 60-70%) appropriately placed int he middle of this range.
The fact that there were no differences observed between the two tissue types, can probably be attributed to the fact that adenomatous polyp metabolism is not significantly altered, so as to introduce changes in Hb oxygenation, SUBSTITUTE SHEET ( ruie 26 ) which is probably related to the disturbed metabolism of such tissues. The technique presented here could be used in vivo for the study of tumors on the surfaces of hollow organs, or for the study of other tissue types when knowledge of Hb saturation is needed.
An intrinsic differentiation in the scattering properties between the two tissue types was observed. For adenomatous polyps, the average effective scattering size was larger, and the average effective scatterer density was smaller, as compared to normal mucosa. There are a number of hypotheses identifying contributions to scattering from various microstructures, both extracellular such as collagen fibers, and intracellular such as mitochondria and cell nuclei. One model provides contributions to light scattering from intracellular structures is increased in adenomatous polyps because cells occupy a higher volume ratio. In addition, the submucosa, in which collagen is more densely packed is usually located too far away from the polyp surface in order to be able to contribute to light scattering. This can explain the lower scatterer density in adenomatous polyps, provided that intracellular scatterers are larger than extracellular ones, on average.
EQUIVALENTS
While this invention has been particularly shown and described with reference to preferred embodiments thereof, it will be understood by those skilled in the art that SUBSTITUTE SHEET ( rule 26 ) various changes in form and details may be made therein without departing from the spirit and scope of the invention as defined by the appended claims. Those skilled in the art will recognize or be able tv ascertain using no more than routine experimentation, many equivalents to the specific embodiments of the invention described specifically herein. Such equivalents are intended to be encompassed in the scope of the claims.
SUBSTITUTE SHEET ( rule 26 )
GOVERNMENT SUPPORT
The invention was supported, in whole or in part, by a Grants No. P41RR02594 and CA53717 from the National Institutes For Health. The Government has certain rights in the invention.
RELATED APPLICATIONS
This is a continuation-in-part of U.S. Serial No.
08/948,734 filed on October 10, 1997, the entire contents of which is incorporated herein by reference.
BACKGROUND OF THE INVENTION
Methods for diagnosis of cancer at an early stage are essential for cancer prevention and therapy. Many types of cancers grow from epithelial tissues, which cover inner and SUBSTITUTE SHEET ( rute 26 ) outer surfaces of the human body. Many of these, for example cancer in gastrointestinal tract, progress through the stage of dysplasia. Dysplasia can be defined as neoplastic tissue which is not malignant yet, but is considered to be a precursor of malignancy. If diagnosed at this stage, most tumors are curable. In the case of gastrointestinal tumors, current methods of diagnosis are based on endoscopy. However, dysplastic tissue is frequently not endoscopically apparent. Thus, detection of dysplasia in the gastrointestinal tract and other sites often relies on sporadic sampling for this "invisible~~
malignant precursor. However, sporadic biopsies have a high probability of missing dysplastic changes. In some cases the biopsy procedure is impossible.
Efforts toward a substitution for standard biopsies have been made in order to provide accurate diagnosis of cancerous tissue in different organs in vivo and in real time. For this purpose, optical techniques that are non-invasive do not require tissue removal and can be performed in-vivo. Such methods provide information at the microscopic level and can thus provide for the search for very small sites which are likely to be missed by standard biopsies. While most human organs can be diagnosed by means of optical techniques, they are particularly applicable to the tissues in human body lumene, since they are easily accessible by optical probes, which can be SUBSTITUTE SHEET ( rule 26 ) inserted into one of the channels of a conventional endoscopic tube.
The present invention relates to the uae of light to determine physical characteristics of a structured layer of material, and in particular certain qualitative information regarding the morphology of tissue structures using scattered light. Both backscattered and transillumination methods can be used, depending upon the thickness of the material and the size and distribution of the structure being measured. Examples of properties of materials that can be measured include surface roughness, parasity, cytometer measurements, or any material in which changes in the refractive index of a material correspond to changes in structures. This type of scattering spectroscopy can be differentiated from absorption spectroscopy which is unable to quantitatively measure particle morphology.
Despite extensive investigations, no reliable optical technique to diagnose dysplasia in-vivo is known. One of the difficulties resides in the fact that dysplastic changes are limited to the uppermost epithelial layer, which can be as thin as 20um, a ane cell layer that is nearly transparent to optical radiation.
Tissue in the gastrointestinal tract, for example (other hollow organs share the same features also), is covered by a layer of cells called epithelium (from 20um SUBSTITUTE SHEET ( rude 26 ) to 300um thick depending on the part of the tract) supported by relatively acellular and highly vascular loose connective tissue, lamina propria, which can be up to 50oum in thickness and contains a network of collagen and elastic fibers, and variety of white blood cell types.
Beneath the lamina propria there is a muscular layer, muscularis mucosae, (up to 400um thick) and another layer of moderately dense connective tissue called submucosa (400-600um thick) containing many small blood vessels and abundant collagen and elastic fibers. The overall thickness of those layers is about lmm. Since a characteristic penetration depth of optical radiation into biological tissue does not usually exceed lmm, for a preferred embodiment it is sufficient to limit measurements of tissue by those layers.
Adenocarcinoma of the esophagus arises in metaplastic columnar epithelial cells in the esophagus, termed "Barrett's esophagus", which is a complication of long-standing gastrointestinal reflex. In this condition, the distal squamous epithelium is replaced by columnar epithelium consisting of a one cell layer which resembles that found in the intestines. Barrett's esophagus is frequently associated with dysplasia which later can progress to cancer. Trials of endoscopic surveillance of patients with Barrett's esophagus have not resulted in a reduction of esophageal cancer mortality. The most likely explanation is that dysplasia occurring 'in the esophagus SUBSTITUTE SHEET ( rule 26 cannot be seen with standard endoscopic imaging and sporadic biopsy sampling is necessary. This procedure can sample only about 0.3% of the tissue at risk. Thus, there is tremendous potential for sampling error.
The application of optical techniques to diagnose dysplasia in Barrett's esophagus is limited by the fact that the primary alterations in the tissue occur in the epithelium which is one cell thick (-20-30um) while fluorescence or reflectance spectra are mostly formed in deeper tissue layers. One of the most prominent features of a dysplastic epithelium is the presence of enlarged, hyperchromatic, and crowded nuclei. In fact, these changes ire nuclei size and spatial distribution are the main markers used by a pathologist to diagnose a tissue specimen as being dysplastic. No significant changes in other tissue layers is observed. Unfortunately, epithelium does not contain strong absorbers or fluorophores, and the thickness of the epithelium is relatively small and thus negligible. These make epithelium diagnosis in Barrett's esophagus to be a difficult problem.
Diffuse reflectance spectroscopy can provide quantitative biochemical and morphological information for the analysis of biological tissue epithelium and the detection of precancerous lesions. Diffuse reflectance spectra were collected from adenomatous colon polyps (cancer precursors) and normal colonic mucosa of patients undergoing colonoscopy. The data were analyzed using an SUBSTITUTE SHEET ( rule 26 ) WO 99/18845 PG"T/US98/21450 analytical light diffusion system, which was measured on a physical tissue model composed of polystyrene beads and hemoglobin. Four parameters were obtained: hemoglobin concentration, hemoglobin oxygen saturation, effective scatterer density, and effective scatterer size. Normal and adenomatous tissue sites exhibited differences in hemoglobin concentration and effective scatterer size.
Thus, diffuse reflectance can be used to obtain tissue biochemical and morphological information in vivo.
A preferred embodiment of the present invention relates to a system of measuring a fine structure component in backscattered light from mucosal tissue which is periodic in wavelength. This structure is ordinarily masked by a diffusive background, which must be removed to render it observable. The origin of this component is due to light which is Mie-scattered by surface epithelial cell nuclei. By analyzing the amplitude and frequency of the periodic structure, the density and size distribution of these nuclei can be extracted. These quantities are important indicators of neoplastic precancerous changes in biological tissue, and the technique can thus provide a useful tool for observing such changes in patients undergoing endoscopy.
The light that is incident on the thin layer at the tissue surface is not completely randomized. In this thin region the details of the elastic scattering process can be preserved. Mucosal tissues, which line the hollow organs SUBSTITUTE SHEET ( rule 26 ) of the body, generally consist of a thin surface layer of epithelial cells supported by underlying, relatively acelluiar connective tissue. In healthy tissues the epithelium often consists of a single, well-organized layer of cells with an endface diameter of about 10-20 a m and a height of about 25 a m. In cancerous and pre-cancerous (dysplastic) epithelium cells proliferate, the cellular layer often thickens and becomes more tightly packed, and the cell nuclei enlarge and appear darker (hyperchromatic) when stained. This may indicate increased nucleic acid density, hence increased refractive index.
A preferred embodiment of the invention utilizes a broadband light source to illuminate the region of interest in the tissue with optical radiation in the range between 350 and 700 nm. A fiber optic probe can be used to deliver and/or collect radiation from the tissue. The system can be used during endoscopy of a patient to optically survey a body lumen within the patient and thereby eliminate the need for removal~of tissue for biopsy, or alternatively, can be used to aid in locating tissue suitable for biopsy.
Backscattered light is preferably collected over a small collection angle of between 2° and 12°, preferably in the range between 3° and 8°. When using an optical fiber system to collect the scattered light fibers having a numerical aperture between 0.05 and 0.22, and preferably between 0.07 and 0.1 can be used. Collection angles within SUBSTITUTE SHEET ( rule 26 ) _g_ this range reduce the level of background light without loss of the periodic component in the returning light.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 is a schematic diagram of a fiber optic probe in accordance with the invention.
Figure 2 is an enlarged view of the distal end of an endoscope in accordance with the invention.
Figures 3A, 3B and 3C illustrate reflectance spectra from cell monolayers for normal colon cells (R - 0.46);
T84 cells (1t - 0.38);~(c) BaSO, diffusing plate (R - 1.0) Figure 4 illustrates nuclear size distributions from data of Figures 3A and 3B, respectively for normal colon cells; and T84 cells respectively. In each case, the solid line is the distribution extracted from the data, and the dashed line is the distribution measured using light microscopy.
Figures 5A, 5B and 5C are reflectance spectra from Barretts~ esophagus for diffuse reflectance from a normal site (solid line), a dysplastic site (dashed line), and the model fit (thick solid line); for corresponding fine structures; and of resulting nuclear size distributions, respectively.
Figure 6 graphically illustrates a comparison of samples analyzed by standard pathology and the optical methods in accordance with the invention.
SUBSTITUTE SHEET ( rule 2G
_g_ Figure 7 is a system used for in vitro tissue analysis in accordance with the invention.
Figure 8 is a process flow diagram illustrating a method of performing an optical diagnosis of tissue in accordance with the invention.
Figure 9 is the molar extinction coefficient spectra (per heme group) of the oxygenated (thin line0 and deoxygenated (thick line) hemoglobin (21). Note the characteristic peaks at 415, 542, and 577 nm {oxyhemoglobin-Hb02) and at 430 and 555 nm (deoxyhemoglobin-Hb).
Figure l0 is the reduced scattering cross section spectra Q' (1~), calculated using Mie theory. Results are shown for four different diameters, d" (0.2, 0.6, 1.0, and 2.0 ~cm). The slope of the spectra is inversely related to the diameter. A refractive index of 1.4 was assumed for the scattering particles, and 1.36 for the surrounding medium.
Figure 11 shows the Diffuse reflectance spectra measured on physical tissue models (thick line) corresponding to four different Hb concentrations: (a) 0.0 mg/dL, (b) 50 mg/dL, (c) 125 mg/dL, (d) 250 mg/dL. The analytical model predictions using the same optical parameters employed in the preparation of the physical tissue models are also shown (thin line), with agreement between the analytical and the tissue model being very good.
SUBSTITUTE SHEET ( ruie 26 ) Figure 12 shows the typical normal and adenomatous polyp spectra (thick line), and best fits to. the data using the model (thin line). Mie theory was used to approximate the reduced scattering coefficient used for the model fits (see Figure 13).
Figure 13 shows the scattering spectra obtained from the data shown in Figure 12 {thin line), and best fits using Mie theory (thick line). The Mie theory fits assign an effective scatterer size d$ to the reduced scattering spectra. The polyp is characterized by a larger effective scatterer size (ds = 1.5 um) as compared to normal mucosa ( d$ = 0 . 3 5 ~Cm) .
Figure 14A-14D show parameters obtained from data analysis: {A) total Hb concentration. Cue, (H) Hb oxygen saturation, a (C) effective scatterer density, pe, and (D) effective scatterer size, d,. The largest difference between normal mucosa (squares) and adenomatous polyps (stars) is observed in the total Hb concentration.
Figure 15 is a binary plot of the total Hb concentration Cue, vs. the effective scatterer size d9,. The normal data tend to form a well defined cluster, while the adenomatous polyp data are marked by wider variation.
The foregoing and other objects, features and advantages of the invention will be apparent from the following more particular description of preferred embodiments thereof, as illustrated in the accompanying drawings in which like reference characters refer to the SUBSTITUTE SHEET ( rule ZG ) WO 99/18845 PCT/US98lZ1450 same parts throughout the different views. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating the principles of the invention.
DETAILED DESCRIPTION OF THE INVENTION
A preferred embodiment of the invention involves the use of a fiber optic system to deliver and collect light from a region of interest to measure one or more physical characteristics of a surface layer. Such a system is illustrated in Figure 1. This system can include a light source 50 such as a broadband source, a fiber optic device 10 for delivery and/or collection of light from the tissue, a detector system 80 that detects the scattered light from the tissue, a computer 120 having a memory 122 that analyzes and stores the detected spectra, and a display 124 that displays the results of the measurement. A lens 60 can be used to couple light from the source 50 into the excitation fiber 30 of the probe 10. A filter 110 and lens system 90,100 can be used to efficiently couple collected light to a spectrograph 70. A controller 140 connected to the data processing system 120 can be connected to a clock and a pulser 150 that controls the light source 50.
The distal end 15 of the probe 10 is illustrated in Figure 2 where the central excitation fiber 30 is surrounded by six peripheral collection fiber 20. The distal end of the device can be enclosed in an optical shield 25 such as that described in U.S. Patent No.
SUBSTITUTE SHEET ( rule 2~ ) WO 99/18845 PGT/US98/~1450 5,199,431, the entire contents of which is incorporated herein by reference. Other endoscopic devices can be used such as an optical needle as described in the above referenced patent or as described in U.S. Patent No.
5,280,788, the entire contents of which is also incorporated herein by reference.
The collection fibers 20 preferably have a numerical aperture in the range of 0.05 to 0.22 in order to provide a desired collection angle from the material being measured.
This aids in reducing background that is removed from scattering spectrum without loss of the periodic component.
The collection fibers can also be replaced or supplemented by a distally mounted imaging sensor 35 such as a charged coupled device or CMOS imager. The sensor has a pixellated structure that is sensitive to the different colors contained in the scattering spectrum being recorded.
Further details regarding the use of a distally mounted sensor can be found in U.S. Serial No. 08/745,509 filed on November 12, 1996, the entire contents of which is incorporated herein by reference.
The backscattered light collected with this system can be analyzed to determine certain physical characteristics of epithelial tissue. The relationship between the collected light and the physical characteristics to be determined using this light can be described as follows.
Epithelial nuclei can be represented as spheroidal Mie scatterers with a refractive index higher than that of the SUBSTITUTE SHEET ( ruie 26 ) wo ~nssas pcrn,rs9sniaso surrounding cytoplasm. Normal nuclei have a characteristic diameter 1=4-7um. In contrast, dysplastic nuclei can be as large as 20 u~a in size, occupying almost the entire cell volume. Thus, in the visible range, the wavelength h « I, and the component of light scattered by the nuclei will exhibit a periodicity with wavelength, the details of which are determined by the nuclear size distribution. The Van de~Hulst approximation can be used to describe the optical scattering cross section of the nuclei:
~f(~,,1) - 1 ~lZ 1 _ sin(28W) + sin(a W) 2 ~ ( 1 2 ~I~, ~I~.
where 8= ~rln~(n-1) , with n~ the refractive index of cytoplasm and n the refractive index of the nuclei relative to that of cytoplasm.
When a beam of light is incident on an epithelial layer of tissue, a portion of this light is backscattered from the epithelial nuclei, while the remainder is transmitted to deeper tissue layers, where it undergoes multiple scattering and becomes randomized. All of the diffusive light which is not absorbed in the tissue eventually returns to the surface, passing once more through the epithelium, where it is again subject to scattering from the cell nuclei. Thus, the emerging light consists of a large diffusive background plus the component of forward scattered and backscattered light from the nuclei in the epithelial layer. For a thin slab of SUBSTITUTE SHEET ( rule 2G ) WO 99/1$845 PCTIUS98I21450 epithelial tissue containing nuclei with size distribution N(I) (number of nuclei per unit area (mm~) and per unit interval of nuclear diameter (um)), the approximate solution of the transport equation for the reflectance R(1~) collected by an optical probe with acceptance solid angle SZ~ is given by the following expression:
R(~,} a rt~~ + 1 1 ~, ~~l) \le~~'' s~~p~~''s' s~~~nr +\Id ~~''s,~z ~~n~ ( 2 ) d ( ~ ~flo where Ii ( tl~. s> ) is the intensity of the incident light delivered in solid angle 52;, Id(~,,s) is the intensity of the light emerging from the underlying tissue, and (1(s)~f~= jt(s)ds for any function I (s) and solid angel ~2, n with s a unit vector pointing outward from the tissue surface in an arbitrary direction. The quantity R(~,) =~Id(~,,s)~n~ I ~l,(~.,s)~~~ is the reflectance of the diffusive background. The optical distance W
z(~,) _ ~Qs(~.,1)N{1)dl and scattering phase function p(~,,s,s')= 1 jp(~,,l,s,s')Crf(~,,1)N(I)dl both depend on N(1) ; for a To sphere, p(~,,l,s,s') is determined by Mie theory. The first term in Eq. (2) describes the attenuation of the diffusive SUBSTITUTE SHEET ( rule 2b ) background, and the terms in brackets describe backscattering of the incident light and forward scattering of diffusive background by the epithelial cell nuclei, respectively.
For small S'2~ the forward scattering term in Eq. (2) can be expanded in T ( 1~) . Thus, ~~Id(~.,s ~~=x~ . l ~Id(~,,s)~o~ a fo + f,r l r,, O.
with zo =~rl2JlZN(l~dl. It is found numerically that fl«fa and that fo and fl are approximately independent of wavelength in the range of interest (~,~;o = 360 to ~,~u = 685nm). Similarly, for the backscattering term ~~I~(.~,-s)p~~.'s s~~~n,~n' l~Id(~,'s)~n~ =bo-b, r/ro. Note that in the forward scattering contribution the first order term oscillates in phase with r(~,~ as required by the optical theorem, whereas for the backscattering contribution it is out of phase. Thus, Eq. (2) reduces to R~~) = a s~'~~ + (1- a '~s~ l~ + bo ~" (.f -b~ ) ~~~) , R (~) zo (~) which shows that the epithelial nuclei introduce a periodic fine structure component into the reflectance with a wavelength dependence similar to that of the corresponding scattering cross section. Its periodicity is approximately proportional to nuclear diameter, and its amplitude is a SUBSTITUTE SHEET ( rule 26 ) function of the size and number of nuclei in the epithelial layer. These quantities can be determined by analyzing the reflectance, R (1~) .
As example of the effects described by Eq. (2), elastic light scattering from normal T84 tumor human colonic cell monolayers (10 and 15 sites respectively) was measured and analyzed. The cells, approximately l5um long, were affixed to glass slides in buffer solution and placed on top of a BaS04 diffusing (and highly reflective) plate. The BaSO, plate was used to approximate the diffuse reflectance from underlying tissue. The diameters of the normal cell nuclei generally ranged from 5 to 7 um and those of the tumor cells from 7 to l6y,m.
An optical fiber probe was used to deliver white light from a xenon arc flashlamp to the samples and collect the return reflectance signal, as shown in Figure 1. The probe tip, 1 mrn in diameter, consisted of a central delivery fiber surrounded by six collection fibers, all of which were covered with a 1 mm thick quartz optical shield. The fibers were 200 urn core fused silica, NA=0.22 ~5~~=S2~=~dVA2~. To eliminate specular reflection, the probe was beveled at 17° to the normal. At the proximal end the collection fibers were arranged in a line and imaged onto the input slit of a spectrograph. A diode array detector recorded the reflectance spectra from 360 to 685 nm.
SUBSTITUTE SHEET ( rule 26 Figures 3A and 38 show the normalized reflectance R (1.) / rt'(?~) from normal and T84 tumor cell samples, respectively. Distinct spectral features are apparent.
For comparison, the reflectance spectrum from the BaS04 plate by itself is also shown in Figure 3C. This spectrum lacks structure and shows no prominent features.
To obtain information about the nuclear size distribution from the reflectance data, Eq.(3) needs to be inverted. The nuclear size distribution, N(1), can then be obtained from the Fourier transform of the periodic component of the opt ical distance z - zo = (I - R(~,)~ / q. The parameter q = 1 - bo - fo +2 (bl - fl) is associated with forward and backward scattering, and depends on the probe geometry and the angular distribution of the incident and reflected light. In this particular example q=0.15. By introducing the effective wavenumber k=2lla~ (n-1) /~,-ko , and ko =2ms~(n-1)l ~,",~,K=2nre~(n-1)~~,n;;" -~,-";~~ and we obtain, K
N(1} = q~ 2 f R~~~ -1 e~ (k + ko )dk. ( 4 ) Equation (4) was used to analyze the data. In order to remove spurious oscillations, N(1) was further processed by convolving it with a Gaussian filtering function. The solid curves in Figure 4 show the resulting SUBSTITUTE SHEET ( ruie 26 ) nuclear size distributions of the normal and T84 cell monolayer samples extracted from the spectra of Figures 3A
and 3B. A nucleus-to-cytoplasm relative refractive index of n=1.06 and cytoplasm refractive index of n~=1.36 were used. The dashed curves show the corresponding size distributions, measured morphometrically via light microscopy. The size distributions can be approximated by Gaussian distributions. The parameters for those are presented in Table 1. The extracted and measured distributions are in good agreement for both normal and T84 cell samples.
Normal Cells Tumor T84 Cells Mean Standard Mean Standard Diameter Deviation Diameter Deviation (gym) (~Cm) (gym) (!gym) Microscopy -.6 ~0.5 10.2 2.0 Spectroscopy6.2 0.45 10.1 2.2 The periodic fine structure in diffuse reflectance of esophagus and colon mucosa of human subjects can be measured during gastroenterological endoscopy procedures.
In the case of Harretts' esophagus, in which the epithelium consists of a thin monolayer of columnar cells. similar to those used in the cell culture experiments, data were collected as in the cell culture studies. The optical fiber probe is inserted into the biopsy channel of the endoscope and brought into contact with the tissue surface.
SUBSTITUTE SHEET ( ruie 26 ) WO 99/18845 PGTlUS98/21450 The methods described herein can also be used to measure structural properties of other GI tissue, tissues in the oral cavity, the cervix, the bladder, and skin.
The fine structure component, which is the scattering signature of the cell nuclei, is typically less then 5% of the total signal and is ordinarily masked by the background of diffusely scattered light from underlying tissue, which itself exhibits spectral features due to absorption and scattering, as shown in Figure 5A. Its spectral features are dominated by the characteristic absorption bands of hemoglobin and collagen scattering. In order to observe the fine structure, this background must be removed. The absorption length, ~Q', ranges from 0.5 to 250 mm as the wavelength is varied, and the effective scattering length (~,,')-1 ranges from 0.1 to 1 mm. Thus, both scattering and absorption have to be taken into account in subtracting or removing the background signal.
To represent the background light incident on the tissue is assumed to be exponentially attenuated, and that at any given depth, z, an amount of light proportional to the reduced scattering coefficient ,uQ is scattered back towards the surface and further exponentially attenuated.
Since light attenuation depends on both scattering and absorption, the attenuation coefficient is assumed to be the sum of absorption coefficient a and effective a scattering coefficient ~.,~°~=~i~u,' . The parameter (3 was SUBSTITUTE SHEET ( ruie 26 ) wo ~nss4s Pcnus9ani4so determined by comparison with Monte Carlo simulations and more accurate models of light transport, and was found to be p~0.0'7. Since light only penetrates ~1 mm into the tissue, most of the diffusely scattered return light is confined to the mucosal layer.
The tissue is thereby represented as a two layer medium and neglected diffusely reflected light from the Lower layer. The following approximate expression for the diffusive light from underlying tissue impinging on the epithelial cell layer is then obtained:
_ _ c~~
la('~~s) = F'(S)~Ir(~~s~nr 1 expf (fps +~~f~a)~J (5) 1 + c( fta I acs ) with F(s) being a Lambertian function describing the angular dependence of light emerging from mucosal layer, L
a parameter representing the thickness of the mucosal layer, and L a parameter representing the thickness of the mucosal layer, and c, the concentration of hemoglobin, which we find to be the main absorber relative to that of collagen, which is responsible for light scattering.
Because both oxygenated and deoxygenated hemoglobin are present, the total hemoglobin absorption is represented as ,uQ=(I-a)~t~~~+afto'~°~~ with oxygen saturation parameter a(0 <_ a S 1).
Figure 5A shows the reflectance spectra from two Barretts~ esophagus tissue sites, both independently SUBSTITUTE SHEET ( rule 2G ) diagnosed by standard pathological analysis to indicate (1) normal and (2) precancerous (i.e. low grade dysplasia). As can be seen, the differences in these unprocessed spectra are small. To analyze them, Eq.(5.) was first fit to the broad features of the data by varying the parameters c, a and L. As seen in Figure 5A, the resulting fits are quite accurate. After removing this diffuse background structure by calculating R(A)/R(a), the periodic fine structure is seen in Figure 5B. Note that the fine structure from the dysplastic tissue site exhibits higher frequency content than that from the normal site. Equation (4) was then employed to extract the respective nuclear size distributions, yielding Figure 5C. The difference between normal and dysplastic tissue sites is evident. The distribution of nuclei from the dysplastic site is much broader than that from the normal site and the peak diameter is shifted from -.7 ~m to about -.10 um. In addition, both the relative number of large nuclei (>l0um) and the total number of nuclei are significantly increased.
Based on computer analysis, the uncertainty of the above method in extracting nuclear size information is estimated to be from 5% to 30%, depending on the noise level and accuracy of the model. The distributions were calculated using the same refractive index for both normal and dysplastic nuclei. This is not entirely correct, inasmuch as in stained histological sections dysplastic nuclei appear hyperchromatic, which maybe indicative of an SUBSTITUTE SHEET ( rule 26 ) WO 99/18845 PCT/US98l21450 increase in refractive index. Thus, the relative number of large nuclei in the distributions measured from dysplastic sites may be slightly overestimated.
The ability to measure nuclear size distribution in vivo has valuable applications in clinical medicine.
Enlarged nuclei are primary indicators of cancer, dysplasia and cell regeneration. In addition, measurement of nuclei of different size can provide information about the presence of particular cells, and can thus serve, for example, as an indicator of inflammatory response of biological tissue. This suggests that different morphology/pathology in the mucosal Iayer gives rise to distinct patterns of nuclear distributions.
The physical characteristics that have been found to be useful to differentiate between Barrett's non-dysplastic and dysplastic epithelium were the total number of nuclei and the percentage of large nuclei ( I > 10 u~). A
comparison of pathological analysis of samples with the optical analysis thereof provided the plot (total number of nuclei vs. percentage of nuclei with a diameter large that 10 um) in Figure 6. From those 50 sites, the cumulative sensitivity and specificity, for this analysis were 83% and 100% respectively. The study had a positive predictive value is 100%. The points indicated by n's were either normal or inflamed and those indicated by d's were displastic. A percentage in the range of 20-30% was found SUBSTITUTE SHEET ( rule 26 ) WO 99/18845 PCTIUS98I~1450 to be an accurate diagnostic for this type, with 25% being used in this particular example.
A preferred embodiment of a spectrograph system 300 employed for the collection of backscattered spectral data from excised tissue samples using a spectrograph and a charge coupled device (CCD), CMOS or other integrated solid state imaging array is illustrated in Figure 7.
System 300 can use a broadband light source or tunable laser 314 for irradiating a sample 46. Source 314 generates a beam 316 which is directed by mirror 318 through focusing optics 320 to impinge on sample 46 mounted on a scattering substrate 325 and behind a transparent window 321. The beam was focused on the sample at an angle of incidence. The collection angle 330 can be determined by an aperture or collimator 340 and is between 2 and 12 degrees, preferably between 3 and 8 degrees.
A portion of the scattered light 322 emitted by sample 46 was collected by collecting optics 324 a small angle relative to the incident light. In another preferred embodiment the angle of incidence and collection can be along a single common axis. Collecting optics 324 collimates and F/matches the collected light for the spectrograph 310. Prior to entering the entrance slit of the spectrograph 310, the collected light was passed through a series of filters 326 which attenuated the unwanted scattered component of the collected light.
SUBSTITUTE SHEET ( rule 25 ) WO 99/1$845 PCTIUS98IZ1450 Figure 8 illustrates generally a process 400 for collecting and analyzing the scattering spectrum from a material of interest such as tissue. The method can be performed both is vitro using a microscopy system or a color imaging system as shown in Figure 7, or in vi vo on a patient. The illuminating light 402 from a source can use radiation in the range of 300nm-1200nm, including the infrared range. After collecting 404 and detecting 406 radiation, the diffuse background 408 can be removed and the desired characteristics calculated 410. These results can be used to provide a diagnosis of the region of interest.
A preferred embodiment of the present invention employs an analytical method based on data collection with an optical fiber probe with fixed delivery and collection geometry. Data analysis uses light diffusion, but rather than directly apply the model to analyze tissue spectra, a correspondence is established between the diffuse reflectance spectra and a physical tissue representation composed of scatterers and absorbers with known optical properties. By analyzing spectra from this tissue model using the analytical formulation, a calibration system is provided which is simple to invert and accurately predicts the concentrations of the scatterers and absorbers. Once the calibration is established, the method is applied to tissue spectra.
SUBSTITUTE SHEET ( ruie 26 ) The following relates to the application of spectral analysis to mucosal surfaces of tissues in vivo. In this example adenomatous colon polyps are measured, which are precursors of colon cancer. These polyps are a form of colonic dysplasia and are histologically similar to visually undetectable flat dysplasia, and are readily detectable. The results are correlated with standard histological examination, and can be used for early detection of disease and, moat importantly, exemplify how this spectroscopic method can be applied in vivo to obtain morphological and biochemical information.
Diffuse reflectance spectra were collected in vivo from adenomatous polyps on 13 patients undergoing routine colonoscopy. Data were collected simultaneously with multi-excitation fluorescence spectra: a xenon-arc flashlamp with 10 acs pulse duration and an average input energy of 4Jj/pulse was used as white light source. An imaging spectrograph dispersed the collected, light and a gated diode array detector was employed for light detection in the 360-685 nm spectral range. A 12 ,sec gate synchronized with the lamp pulse was used to minimize background from endoscopic illumination. The detector was controlled by a PC notebook computer, where the data were transferred and stored.
Light was delivered and collected using an optical fiber probe which was advanced through the accessory channel of the colonoscope and brought into contact with SUBSTITUTE SHEET ( rule 26 ) WO 99/18845 PGTIUS98l21450 the tissue. The probe consisted of a central optical fiber for light delivery, surrounded by six concentric fibers for light collection. All fibers had 200 ~cm core diameter and NA=0.22. The probe tip was fitted with a quartz shield approximately 1.5 mm in length and diameter, which provided a fixed delivery/collection geometry with uniform circular delivery and collection spots in the form of overlapping cones with approximate radii of rd=0.35 mm and r~=0.55 mm, respectively. The tip was beveled at an angle of 17 degrees, to eliminate unwanted specular reflections from the shield/air interface.
The diffuse reflectance spectrum of a 20% by volume BaS04 powder suspension was used as a reference, to take into account the spectral characteristics and overall intensity of the xenon lamp. The probe was immersed in the suspension and a reference diffuse reflectance spectrum was recorded prior to collection of each data set. Tissue spectra were calibrated by dividing by this reference spectrum. Diffuse reflectance spectra were measured from a few different sites on every adenomatous polyp and from corresponding sites in the surrounding normal mucosa.
Single-pulse excitation was used in order to avoid motional artifacts. The polyps were than removed and examined histologically, while the normal mucosa sites were not biopsied.
To represent diffuse reflectance, biological tissue was approximated as being a homogeneous semi-infinite SUBSTITUTE SHEET ( rule 26 ) turbid medium with reduced scattering and absorption coefficients ~,,' (A) and ~Ca' (1~) , respectively (?~ is the wavelength of light). Part of the incident light is absorbed in the tissue, while the non-absorbed part is subject to multiple scattering and eventually emerges from the surface as diffuse reflectance. A certain fraction of this return light is collected by the probe, while the remaining part escapes undetected. The amount of the light collected depends on the optical properties ~c9' (a) and ~.
(h), as well as on the probe diameter, rp. Because r~ is finite, it serves as a scale length, enabling ice' (1~) and ' (1~) to be determined separately.
To characterize light collection by an optical probe, knowledge of the spatial and angular resolution of the diffuse reflectance on the surface of the tissue is required. Using the method of images to implement the diffusion approximation to the radiative transfer equation the diffuse reflectance radial density, R (1~, r), at a distance r from the point of incidence of the light on the surface of a semi-infinite turbid medium is given by ~~~~r~=4~ of~s (~+~)e~~~~ _(1+3A)(f~+r )er~ ~ (6) s ~r 1 1 z z Ilz where ~ _ (3,uQ (f~a - fps )) ~ zo , ~s +~a and r, =(zo +rz~'n,r2 -Czo(1+ 3 A)z +rzJ
SUBSTITUTE SHEET ( rule 26 ) The parameter A depends on the refractive index n of the medium (A=1 for n=1 and A>1 for n>1). A reasonable assumption for the average refractive index of colon tissue is n~ 1.4 so that A ~ 3.2.
To find the total light collected by the probe, Eq. 6 must be integrated over the spatial extend of the delivery and collection areas, characterized by radii rd and r~, respectively. Assuming the incident light intensity to be uniform over the entire delivery area, the diffuse reflectance Rp (2~) collected by the probe is given by r yx r Rp(~.)= ~ ~rdrld~~R(~.,r-r)rdr~ r ('1) with ~ r - r'~ _ ~rz + r2 - 2rr' cos~)~~j . The integral s i s Eq . 7 can be evaluated numerically. However, to obtain a simple analytical expression for R.~ (A), we assume point delivery of light (rd = 0) and collection over a circular spot of radium r~, we then obtain:
r Rp(~.) = 2~~ R(r)rdr SUBSTITUTE SHEET ( rule 26 ) -(1+1~~~° e-d.~ 4 e-~i - ~s e-'"° xe l 3 -za ; -(1+-A)za , (8) ,us +,uQ r~ 3 r2 i/2 2 Z l/2 , l with r2 =(zo +r~ ) ,r~ = zo~l+ 3 AJ +r~
The optimal value of r~ was found by calibrating Eq. 8 on physical tissue models with known optical properties. The S advantage of using Eq. 8 is that it is much easier to invert than Eg. 7, which requires numerical integration.
Eq. 8 gives the diffuse reflectance at the perpendicular direction to the tissue surface. This is acceptable because light is only collected by the optical probe at directions with a maximum deviation of approximately 10 degrees from the direction perpendicular to the surface.
Eq. a can be used to analyze the diffuse reflectance spectra collected by the probe. From these measurements of the tissue spectra, hemoglobin is the only significant light absorber in colon tissue in the visible range of the spectrum, and is encountered in both oxygenated and deoxygenated forms. The light absorption properties of both forms have been studied and their molar extinction coefficient spectra E~2 (A) , e~, (1~) are shown in Figure 9.
Oxyhemoglobin absorption presents a maximum at 415 nm and two secondary maxima at 542 and 577 nm, while deoxyhemoglobin has a maximum at 430 nm and only one SUBSTITUTE SHEET ( rule 26 ) WO 99118845 PG"fIUS98/Z1450 secondary maximum at 555 nm. The total absorption coefficient, ~Cj (A) is given by f~Y~'~~=2.3Chb~asbbo,~'~)+(1-a~E~b~'~)) , (9) where a = C'~°= is the Hb oxygen saturation parameter, ChbO~ + Chb S CbbO~and C~ are the concentrations of oxy and deoxy Hb, respectively, and C~b - Cb~z + C~ the total concentration o f HB .
Determination of Cue, and a was performed in the following way. For a given tissue spectrum, R.p(1~), initial values were assigned (typically C~ = 0.0 and a = 0.5).
Eq. 8 was then numerically inverted to find ~s' (1~), which exhibited residual spectral features of HB absorption. The parameters C,~ and a were then modified, and the process was repeated recursively until ~.S' (1~) exhibited a smooth spectral shape with the Hb spectral features absent. In this way, ~.,' (A) was simultaneously determined with Cue, and a.
Table 2 Model Normal Adenomatous Parameter Polyp SUBSTITUTE SHEET ( rule 26 Total Hb Concentration C~ (mg/dL) 13.6 t 72.0 29.2 a.s Hb Oxygen Saturation 0.59 ~ 0.63 0.10 a 0.08 Effective Scatterer Density 9.2 ~ 3.5 4.0 ps (xl0e mm-3) 7.5 Effective Scatterer Size 0.56 ~ 0.94 0.44 de (mm) 0.18 The above procedure is based on the assumption that ,g' (?,.) is a relatively smooth function of the wavelength A, which analysis confirms, as will become evident from the discussion below. In general, ~Ca' (1~) is the sum of contributions from the various tissue scatterers.
Unfortunately, detailed information about these individual scatterers is not available . Therefore, ~,e' (1~) was written as f~s~'~~ = Ps~~~~~~ ( 10 ) SUBSTITUTE SHEET ( rule 26 ) with p, the effective scattering density and o' (h) the effective reduced scattering cross section, i.e, the tissue scattering properties are modeled in an average way, as if tissue contained a single well-defined type of scatterer.
In general, a' (1~) depends on the refractive index, shape and size of the scatterer, as well as on the refractive index of the surrounding medium. For a spherical scatterer with diameter d8, o' (1~) can be calculated numerically using Mie scattering theory.
Figure 10 shows such a calculation of a' (1~)., Note that the slope of Q.' (J~) depends on ds in a simple way i . a .
the slope is inversely related to scatterer size. In this way it was possible to assign a scatterer size to every a' (?~) and hence to every ~.a' (J~) in the range ds = 0.2-2.0 um. For example, by inspecting ~.,' (1~) of normal colon mucosa, previously reported based on in vitro measurements, it can be seen that they correspond to a scatterer size d$
0.35 ~Cm. Once da was determined, the density p~ was by dividing ~B' (1~) by Q' (h) . In summary, for each tissue diffuse reflectance spectrum four parameters were obtained, Cue" a , p~ and d9 .
In calculating the results shown in Figure 10, the scatterer and the surrounding medium refractive indices were assumed similar to those likely to be found in tissue.
Reasonable approximations are a refractive index of approximately 1.4 for the scatterers and 1.36 for the surrounding medium. These values can be justified by SUBSTITUTE SHEET ( rule 26 noting that the lower bound for the tissue refractive index is set by the refractive index of water, which is approximately equal to 1.33 in the visible range, and the upper bound is set by the maximum refractive index reported for soft tissue, which is around 1.45. Such values are consistent with those generally observed for soft biological tissues.
The physical tissue representation served as a method for confirming the applicability of the various approximations made in developing Eq. 8. The samples consisted of mixtures of spherical microparticles with Hb in various concentrations. The model established that these mixtures simulated the optical properties of tissue samples. In addition, the range of validity of the analytical model in terms of the optical properties was established, and the optimal value for the parameter r~, Eq. 8. was determined.
Polystyrene bead suspensions in de-ionized water (Polysciences, Inc.) were used to simulate tissue light scattering, and Hb solutions prepared from lyophilized human Hb (Sigma, H0267) were used to stimulate absorption.
The scattering properties of the beads were calculated using Mie theory. The bead diameter was 1.07 ~Cm, and the refractive index np of polystyrene was given by the expression of np = 15607 + 10002/ 1~~ (26) , (A in nm) , and the polystyrene concentration was 0.625 by volume. The reduced scattering coefficient varied from approximately SUBSTITUTE SHEET ( ruie 26 ) WO 99118845 PC'f/US98I21450 1.7 mm-1 at 400 nm. This spectral dependence is similar to that shown in Figure 10 with dA = 1.0 ~cm, with the difference that the slope is larger due to the larger refractive index of polystyrene.
Since light absorption by polystyrene is negligible in the visible range, absorption was solely due to oxyhemoglobin. The size of the physical-tissue model was approximately 3x3x0.5 cm, simulating the flat geometry of normal colon mucosa. Additional geometries were investigated such as a cylindrical geometry with 1 cm depth and 0.5 cm diameter, to simulate the geometry of the polyps, but no significant spectral differences were found.
The range of optical parameters used was chosen based on the previously reported independent measurements of colon tissue optical parameters performed in vitro.
Figure 11 shows diffuse reflectance spectra measured on the physical tissue model with various concentrations of Hb vs. the analytical model predictions, which were obtained by setting r~ = 0.45 mm in Eq. 3. This was determined to be the optimal value for r~, which was kept fixed throughout the entire data analysis. It was also found that the parameter Zo = 1/ (0. 6~d + ~,,' ) improved the agreement between the analytical model and the. physical tissue model data, especially for large values of absorption. The physical tissue model spectra shown in Figure lI are very similar to the tissue spectra presented below. This fact serves as indirect confirmation of the SUBSTITUTE SHEET ( rule 26 ) wo ~n~s PCTIUS98121450 assumptions made in developing the model, regarding tissue scatterers (modeled as microspheres) and tissue absorption (attributed to Hb).
The analytical model was found to accurately predict the physical tissue model spectra for Hb concentrations in the physiological range of interest. For Hb concentrations lower than 100 mg/dL, the deviation betv~ieen the two models was always smaller than 10% over the entire wavelength range. The largest deviation occurred when absorption became comparable to scattering. This is shown in curve (d) of Figure ll, near the peak of Hb absorption, around 415 nm. The Hb concentration was in this case 250 mg/dL
which corresponds to an absorption coefficient of approximately 5 mm-1 at 415 nm, while the scattering coefficient was approximately 2.8 mm-1 at the same wavelength.
Figure 12 shows typical diffuse reflectance spectra from one adenomatous polyp site and one normal mucosa site.
Significant spectral differences are readily observable, especially in the blue region of the spectrum, where the Hb absorption valley around 420 nm is the prominent spectral feature. This valley is much more prominent int he polyp spectrum, which also shows a continuous decrease in intensity starting from the red end (-700 nm) and moving toward the green region (--500 nm) of the spectrum, while in the same range the normal mucosa spectrum shows a steady increase in intensity. The secondary absorption dips of SUBSTITUTE SHEET ( rule 26 ) wo ~nss4s rrr~s9sm4so oxyhemoglobin (542 and 577 nm) are much more prominent in the adenomatous polyp spectrum, indicating increased Hb concentration. According to the model analysis the normal mucosa spectrum was characterized by Hb concentration C,~, _ 22.5 mg/dL, while the corresponding value for the adenomatous polyp was about 6 times higher (C~ = 165 mg/dL). The Hb saturation was found to be 0.65 t 0.05, and 0.55 ~ 0.05 respectively.
Figure 13 shows the scattering spectra ~.$' (h) calculated from the data shown in Figure 12, along with the best Mie theory fits. The main difference between the spectra of the two tissue types is observed in the spectral slope, which corresponds to different effective scattering sizes, de = 1.5 ~,m for the polyp and de = 0.35 ~,m for normal mucosa. The values for the scatterer densities were found to be pa = 1:5x108 mm-' for the normal mucosa, and pe =
1.3x108 mm-3 for the adenomatous polyp. Figure 12 also shows the best analytical model fits to the data, using Eq.
8. The model accurately describes the data, despite the dramatic differences noted in the spectral shape between the two tissue types and the fact that GCB' (A) is approximated assuming a homogeneous distribution of spherical scatterers. The deviation between the data and the model in typically smaller than 10~ for most of the wavelength range.
Figures 14A-14D shows the calculated values of the four parameters for all tissue sites studied: (A) total Hb SUBSTITUTE SHEET ( ruie 26 ) WO 99118845 PCTlUS98l11450 concentration C,~ (B) Hb oxygen saturation a, (C) effective scatterer density p, and (D) effectiveness scatterer size d,. Adenomatous polyps were clearly characterized by increased Hb concentration, while there were no observable differences in terms of the Hb oxygen saturation. The effective scatterer density was in general lower in adenomatous polyps, and the effective scatterer size larger, even though there was significant overlap of these parameter distributions between the two tissue types.
Table 2 summarizes the results shown in Figures 14A-14D by giving the average values and the standard deviations for each parameter.
Figure 15 shows a plot of the Hb concentration C,~, vs. the effective scatterer size de. These two parameters are shown together in order to summarize and illustrate the differences found in the scattering and absorption properties of normal mucosa and adenomatous polyps in the colon. Note that the normal mucosa data tend to form a cluster, while the adenomatous polyp data are separated, and characterized by a wider spread and irregular distribution, in both the effective scatterer size and the Hb concentration.
A methodology has been described which provides quantitative information about colon mucosal tissues in vivo, based on diffuse reflectance measurements. The main components of this methodology are (a) data collection through an optical fiber probe with a fixed SUBSTITUTE SHEET ( ruie 2G ) wo ~ns84s rcrn.rs9sni4so delivery/collection geometry, (b) an analytical model for data analysis based on light diffusion, and (c) a physical tissue model for calibration of the analytical model.
The use of an optical probe with fixed geometry enables consistent data collection, and independent determination of the scattering and absorption. Modeling of the probe geometry is facilitated through the use of the parameter r~, which also defined the probe s sensitivity to absorption. A probe with large r~ will render the spectra collected more sensitive to tissue absorption as compared to a probe with a smaller r~. In Figure 4, the secondary Hb absorption peaks are barely noticeable in the normal mucosa spectrum: a probe with larger r~ would make these features more prominent.
The analytical diffusion theory model is amenable to numerical inversion and successfully describes the tissue data after calibration on the physical tissuemodel composed of polystyrene beads and oxy hemoglobin. Other researchers have already used variants of the analytical model described here, in the study of diffuse reflectance from tissues and physical tissue models in the IR range. The present study is, to our knowledge, the first to apply the model in the visible range, to in vivo data from human mucosal tissue, measured with an optical fiber probe. By working in the visible rather than in the IR, light penetration was restricted to approximately 0.5 mm, i.e.
the mucosa layer where precancerous changes occur. Using SUBSTITUTE SHEET ( ruie 26 ) the model, we have shown that it is possible to obtain quantitative information about the tissue studied, such as Hb concentration, Hb oxygen saturation, effective scatterer size, and effective scatterer density. The results show that diffuse reflectance provides a tool for quantitative analysis of mucosal tissue surfaces in vivo.
' The basic approximation made in the model is that Hb is the only significant absorber in colon mucosa in the visible range of the spectrum. Even though this assumption IO lacks direct confirmation, the fact that the data strongly exhibit the characteristic features of Hb absorption, clearly indicates that Hb is a major absorber. In addition, the spectra measured on the tissue physical model, in which Hb was the only absorber, closely resemble the tissue spectra.
In a similar way, tissue scattering was modeled as due to homogeneous spherical scatterers with known refractive index. The approximation permits a quantitative characterization in terms of two basic parameters, the effective scatterer size and the effective scatterer density. Theae parameters provide an estimate of the average scattering properties. The fact that the spectra measured on physical tissue models reproduce the actual tissue spectra, serves again (as in the case of Hb), as an indirect confirmation of the validity of this approximation.
SUBSTITUTE SHEET ( rule 26 ) Data analysis showed that adenomatous colon polyps were characterized by increased Hb concentration. It is known that tumors and cancerous tissues exhibit increased microvasculature, and hence increased blood content. Using morphometry and vascular casting in combination with scanning electron microscopy techniques. Precancerous tissues such as adenomatous polyps of the colon are also characterized by increased microvascular volume the above in agreement with these reports in terms of observing the IO increased Hb concentration. Others report increased microvascularity of the colon mucosa associated with Crohn~s disease and ulcerative colitis. Even though we did not study these tissue types, the technique employed here could prove useful for the in vivo study of such diseases.
The Hb oxygen saturation was found to be approximately 60%, on average, for both normal mucosa and adenomatous polyps. This result is reasonable, because the measurements were essentially performed in the capillary network of the mucosa, where oxygen is transferred from Hb to tissue. Hb oxygen saturation drops within the capillaries from approximately 97% (arterial blood) to about 40% (venous blood) with the measured values (around 60-70%) appropriately placed int he middle of this range.
The fact that there were no differences observed between the two tissue types, can probably be attributed to the fact that adenomatous polyp metabolism is not significantly altered, so as to introduce changes in Hb oxygenation, SUBSTITUTE SHEET ( ruie 26 ) which is probably related to the disturbed metabolism of such tissues. The technique presented here could be used in vivo for the study of tumors on the surfaces of hollow organs, or for the study of other tissue types when knowledge of Hb saturation is needed.
An intrinsic differentiation in the scattering properties between the two tissue types was observed. For adenomatous polyps, the average effective scattering size was larger, and the average effective scatterer density was smaller, as compared to normal mucosa. There are a number of hypotheses identifying contributions to scattering from various microstructures, both extracellular such as collagen fibers, and intracellular such as mitochondria and cell nuclei. One model provides contributions to light scattering from intracellular structures is increased in adenomatous polyps because cells occupy a higher volume ratio. In addition, the submucosa, in which collagen is more densely packed is usually located too far away from the polyp surface in order to be able to contribute to light scattering. This can explain the lower scatterer density in adenomatous polyps, provided that intracellular scatterers are larger than extracellular ones, on average.
EQUIVALENTS
While this invention has been particularly shown and described with reference to preferred embodiments thereof, it will be understood by those skilled in the art that SUBSTITUTE SHEET ( rule 26 ) various changes in form and details may be made therein without departing from the spirit and scope of the invention as defined by the appended claims. Those skilled in the art will recognize or be able tv ascertain using no more than routine experimentation, many equivalents to the specific embodiments of the invention described specifically herein. Such equivalents are intended to be encompassed in the scope of the claims.
SUBSTITUTE SHEET ( rule 26 )
Claims (15)
1. A method of optically analyzing a material comprising:
collecting light from a material:
detecting a scattering spectrum from the collected light; and measuring a component of the detected light that is periodic in wavelength to determine a physical characteristic of the material.
collecting light from a material:
detecting a scattering spectrum from the collected light; and measuring a component of the detected light that is periodic in wavelength to determine a physical characteristic of the material.
2. The method of Claim 1 further comprising analyzing the detected scattered light with a data processor.
3. The method of Claim 1 further comprising collecting the light from the material with a fiber optic probe, the probe having an optical fiber with a numerical aperture in a range of 0.05-0.25.
4. The method of Claim 1 further comprising determining an average nuclear size of nuclei with the region of interest.
5. The method of Claim 1 further comprising measuring a number of particles per unit area within the region of interest.
6. The method of Claim 1 further comprising forming a spectral representation from the detected light and removing a diffuse spectral background from the spectral representation.
7. The method of Claim 1 further comprising detecting the light with an imaging sensor.
8. An apparatus for optically measuring tissue comprising:
a light source that illuminates a region of interest in tissue to be measured;
an optical system that collects scattered light from the tissue;
a detector system that senses the collected light; and a data processor that analyzes a structured component in the scattered light which is periodic in wavelength to determine a physical characteristic of the tissue.
a light source that illuminates a region of interest in tissue to be measured;
an optical system that collects scattered light from the tissue;
a detector system that senses the collected light; and a data processor that analyzes a structured component in the scattered light which is periodic in wavelength to determine a physical characteristic of the tissue.
9. The apparatus of Claim 8 further comprising a broadband light source that generates light in a range of 350-700 nm.
10. The apparatus of Claim 8 further comprising a fiber optic probe that couples the source to the tissue.
11. The apparatus of Claim 8 further comprising a fiber optic probe that collects the light in a collection angle between 2 and 12 degrees.
12. The apparatus of Claim 11 where in the probe is insertable in an endoscope.
13. The apparatus of Claim 8 wherein the detector system comprises an imaging sensor and a spectrograph.
14. The apparatus of Claim 8 wherein the data processor removes a diffuse spectral background component from the detected scattered light.
15. The apparatus of Claim 8 further comprising a filter that removes components of the collected light.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/948,734 | 1997-10-10 | ||
US08/948,734 US6091984A (en) | 1997-10-10 | 1997-10-10 | Measuring tissue morphology |
PCT/US1998/021450 WO1999018845A1 (en) | 1997-10-10 | 1998-10-09 | Method for measuring tissue morphology |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2305898A1 true CA2305898A1 (en) | 1999-04-22 |
Family
ID=25488203
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002305898A Abandoned CA2305898A1 (en) | 1997-10-10 | 1998-10-09 | Method for measuring tissue morphology |
Country Status (9)
Country | Link |
---|---|
US (2) | US6091984A (en) |
EP (1) | EP1021126B1 (en) |
JP (1) | JP2001519190A (en) |
CN (1) | CN1278153A (en) |
AT (1) | ATE271830T1 (en) |
AU (1) | AU9693298A (en) |
CA (1) | CA2305898A1 (en) |
DE (1) | DE69825303T2 (en) |
WO (1) | WO1999018845A1 (en) |
Families Citing this family (184)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6091984A (en) | 1997-10-10 | 2000-07-18 | Massachusetts Institute Of Technology | Measuring tissue morphology |
US6404497B1 (en) | 1999-01-25 | 2002-06-11 | Massachusetts Institute Of Technology | Polarized light scattering spectroscopy of tissue |
CN1341003A (en) * | 1999-01-26 | 2002-03-20 | 牛顿实验室公司 | Autofluorescence imaging system for endoscopy |
JP4954418B2 (en) * | 2000-03-31 | 2012-06-13 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Method and apparatus for locating anomalous regions in turbid media |
US20020107448A1 (en) * | 2000-10-06 | 2002-08-08 | Gandjbakhche Amir H. | Probe using diffuse-reflectance spectroscopy |
ATE454845T1 (en) * | 2000-10-30 | 2010-01-15 | Gen Hospital Corp | OPTICAL SYSTEMS FOR TISSUE ANALYSIS |
US9295391B1 (en) | 2000-11-10 | 2016-03-29 | The General Hospital Corporation | Spectrally encoded miniature endoscopic imaging probe |
JP2002153414A (en) | 2000-11-17 | 2002-05-28 | Asahi Optical Co Ltd | Electron endoscope and electron endoscope system |
US6697652B2 (en) | 2001-01-19 | 2004-02-24 | Massachusetts Institute Of Technology | Fluorescence, reflectance and light scattering spectroscopy for measuring tissue |
US6600947B2 (en) | 2001-03-16 | 2003-07-29 | Nymox Corporation | Method of detecting amyloid-containing lesions by autofluorescence |
US20020165456A1 (en) * | 2001-03-26 | 2002-11-07 | Murat Canpolat | Estimation of the average size of white light scatterers in normal and cancerous tissue using light scattering spectrum |
EP2333523B1 (en) * | 2001-04-30 | 2020-04-08 | The General Hospital Corporation | Method and apparatus for improving image clarity and sensitivity in optical coherence tomography using dynamic feedback to control focal properties and coherence gating |
WO2002088705A2 (en) * | 2001-05-01 | 2002-11-07 | The General Hospital Corporation | Method and apparatus for determination of atherosclerotic plaque type by measurement of tissue optical properties |
JP5259033B2 (en) * | 2001-08-03 | 2013-08-07 | オリンパス株式会社 | Endoscope system |
US6980299B1 (en) * | 2001-10-16 | 2005-12-27 | General Hospital Corporation | Systems and methods for imaging a sample |
US8308797B2 (en) | 2002-01-04 | 2012-11-13 | Colibri Heart Valve, LLC | Percutaneously implantable replacement heart valve device and method of making same |
EP2327954A1 (en) * | 2002-01-11 | 2011-06-01 | The General Hospital Corporation | Apparatus for OCT imaging with axial line focus for improved resolution and depth of field |
US7355716B2 (en) | 2002-01-24 | 2008-04-08 | The General Hospital Corporation | Apparatus and method for ranging and noise reduction of low coherence interferometry LCI and optical coherence tomography OCT signals by parallel detection of spectral bands |
US8131332B2 (en) * | 2002-04-04 | 2012-03-06 | Veralight, Inc. | Determination of a measure of a glycation end-product or disease state using tissue fluorescence of various sites |
US7672713B2 (en) * | 2002-06-19 | 2010-03-02 | Infraredx, Inc. | Multi-channel catheter tip |
WO2004016155A2 (en) * | 2002-08-16 | 2004-02-26 | The Government Of United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Apparatus for multifocal deposition and analysis and methods for its use |
JP4632645B2 (en) * | 2002-12-12 | 2011-02-16 | オリンパス株式会社 | Imaging device and processor device |
US8054468B2 (en) | 2003-01-24 | 2011-11-08 | The General Hospital Corporation | Apparatus and method for ranging and noise reduction of low coherence interferometry LCI and optical coherence tomography OCT signals by parallel detection of spectral bands |
US7761139B2 (en) | 2003-01-24 | 2010-07-20 | The General Hospital Corporation | System and method for identifying tissue using low-coherence interferometry |
JP4805142B2 (en) | 2003-03-31 | 2011-11-02 | ザ ジェネラル ホスピタル コーポレイション | Speckle reduction in optically interfering tomography by combining light of different angles with varying path length |
US7102758B2 (en) | 2003-05-06 | 2006-09-05 | Duke University | Fourier domain low-coherence interferometry for light scattering spectroscopy apparatus and method |
KR20130138867A (en) | 2003-06-06 | 2013-12-19 | 더 제너럴 하스피탈 코포레이션 | Process and apparatus for a wavelength tunning source |
JP4535697B2 (en) * | 2003-07-23 | 2010-09-01 | オリンパス株式会社 | Endoscope device for light scattering observation of biological tissue |
KR101321413B1 (en) | 2003-10-27 | 2013-10-22 | 더 제너럴 하스피탈 코포레이션 | Method and apparatus for performing optical imaging using frequency-domain interferometry |
US7551293B2 (en) * | 2003-11-28 | 2009-06-23 | The General Hospital Corporation | Method and apparatus for three-dimensional spectrally encoded imaging |
US7263438B2 (en) * | 2003-12-23 | 2007-08-28 | Honda Motor Co., Ltd. | Smart storage and transmission of navigation information |
SE0400145D0 (en) * | 2004-01-27 | 2004-01-27 | Anders Johansson | An arrangement and method for assessing joints |
US20060155178A1 (en) * | 2004-03-26 | 2006-07-13 | Vadim Backman | Multi-dimensional elastic light scattering |
US20050261829A1 (en) * | 2004-05-19 | 2005-11-24 | Honda Motor Co., Ltd. | System and method for off route processing |
AU2004320269B2 (en) | 2004-05-29 | 2011-07-21 | The General Hospital Corporation | Process, system and software arrangement for a chromatic dispersion compensation using reflective layers in optical coherence tomography (OCT) imaging |
EP1774325B1 (en) * | 2004-06-17 | 2016-02-24 | Massachusetts Institute of Technology | Methods for identifying stem cells based on nuclear morphotypes |
JP4995720B2 (en) | 2004-07-02 | 2012-08-08 | ザ ジェネラル ホスピタル コーポレイション | Endoscopic imaging probe with double clad fiber |
US8081316B2 (en) | 2004-08-06 | 2011-12-20 | The General Hospital Corporation | Process, system and software arrangement for determining at least one location in a sample using an optical coherence tomography |
EP2272420B1 (en) | 2004-08-24 | 2013-06-19 | The General Hospital Corporation | Apparatus for imaging of vessel segments |
WO2006024014A2 (en) | 2004-08-24 | 2006-03-02 | The General Hospital Corporation | Process, system and software arrangement for measuring a mechanical strain and elastic properties of a sample |
JP5215664B2 (en) * | 2004-09-10 | 2013-06-19 | ザ ジェネラル ホスピタル コーポレイション | System and method for optical coherence imaging |
US20060094940A1 (en) * | 2004-09-21 | 2006-05-04 | Art, Advanced Research Technologies, Inc. | Method for selecting wavelengths for optical data acquisition |
EP1804638B1 (en) | 2004-09-29 | 2012-12-19 | The General Hospital Corporation | System and method for optical coherence imaging |
EP1819270B1 (en) * | 2004-10-29 | 2012-12-19 | The General Hospital Corporation | Polarization-sensitive optical coherence tomography |
JP5623692B2 (en) * | 2004-11-02 | 2014-11-12 | ザ ジェネラル ホスピタル コーポレイション | Optical fiber rotator, optical system and method for sample imaging |
US7417740B2 (en) * | 2004-11-12 | 2008-08-26 | Medeikon Corporation | Single trace multi-channel low coherence interferometric sensor |
EP2278266A3 (en) | 2004-11-24 | 2011-06-29 | The General Hospital Corporation | Common-Path Interferometer for Endoscopic OCT |
JP2008521516A (en) | 2004-11-29 | 2008-06-26 | ザ ジェネラル ホスピタル コーポレイション | Configuration, apparatus, endoscope, catheter, and method for performing optical image generation by simultaneously illuminating and detecting multiple points on a sample |
US7428048B1 (en) | 2004-12-30 | 2008-09-23 | Spectral Molecular Imaging Inc. | Imaging elastic scattering spectroscopy |
US7725169B2 (en) * | 2005-04-15 | 2010-05-25 | The Board Of Trustees Of The University Of Illinois | Contrast enhanced spectroscopic optical coherence tomography |
ES2337497T3 (en) | 2005-04-28 | 2010-04-26 | The General Hospital Corporation | EVALUATION OF CHARACTERISTICS OF THE IMAGE OF AN ANATOMICAL STRUCTURE IN IMAGES OF TOMOGRAPHY OF OPTICAL COHERENCE. |
US7859679B2 (en) | 2005-05-31 | 2010-12-28 | The General Hospital Corporation | System, method and arrangement which can use spectral encoding heterodyne interferometry techniques for imaging |
JP5702049B2 (en) | 2005-06-01 | 2015-04-15 | ザ ジェネラル ホスピタル コーポレイション | Apparatus, method and system for performing phase resolved optical frequency domain imaging |
WO2007014213A2 (en) * | 2005-07-25 | 2007-02-01 | Massachusetts Institute Of Technology | Tri modal spectroscopic imaging |
CN101238347B (en) | 2005-08-09 | 2011-05-25 | 通用医疗公司 | Apparatus, methods and storage medium for performing polarization-based quadrature demodulation in optical coherence tomography |
CN101360447B (en) | 2005-09-29 | 2012-12-05 | 通用医疗公司 | Method and apparatus for optical imaging via spectral encoding |
US20070173736A1 (en) * | 2005-10-07 | 2007-07-26 | Femspec Llc | Apparatus and methods for endometrial biopsies |
US8537366B2 (en) * | 2005-10-11 | 2013-09-17 | Duke University | Systems and methods for endoscopic angle-resolved low coherence interferometry |
PT2444783E (en) * | 2005-10-11 | 2015-06-17 | Univ Duke | Systems and method for fiber-based endoscopic angle-resolved low coherence interferometry |
WO2007047690A1 (en) | 2005-10-14 | 2007-04-26 | The General Hospital Corporation | Spectral- and frequency- encoded fluorescence imaging |
US20070129615A1 (en) * | 2005-10-27 | 2007-06-07 | Northwestern University | Apparatus for recognizing abnormal tissue using the detection of early increase in microvascular blood content |
US9314164B2 (en) | 2005-10-27 | 2016-04-19 | Northwestern University | Method of using the detection of early increase in microvascular blood content to distinguish between adenomatous and hyperplastic polyps |
US20070179368A1 (en) * | 2005-10-27 | 2007-08-02 | Northwestern University | Method of recognizing abnormal tissue using the detection of early increase in microvascular blood content |
US20090203977A1 (en) * | 2005-10-27 | 2009-08-13 | Vadim Backman | Method of screening for cancer using parameters obtained by the detection of early increase in microvascular blood content |
JP5680826B2 (en) | 2006-01-10 | 2015-03-04 | ザ ジェネラル ホスピタル コーポレイション | Data generation system using endoscopic technology for encoding one or more spectra |
WO2007084995A2 (en) | 2006-01-19 | 2007-07-26 | The General Hospital Corporation | Methods and systems for optical imaging of epithelial luminal organs by beam scanning thereof |
US20070223006A1 (en) * | 2006-01-19 | 2007-09-27 | The General Hospital Corporation | Systems and methods for performing rapid fluorescence lifetime, excitation and emission spectral measurements |
WO2007084903A2 (en) | 2006-01-19 | 2007-07-26 | The General Hospital Corporation | Apparatus for obtaining information for a structure using spectrally-encoded endoscopy techniques and method for producing one or more optical arrangements |
WO2007084959A1 (en) * | 2006-01-20 | 2007-07-26 | The General Hospital Corporation | Systems and methods for providing mirror tunnel microscopy |
US8131112B1 (en) | 2006-01-23 | 2012-03-06 | Sandia Corporation | Method for detecting cancer in a single cell using mitochondrial correlation microscopy |
US7787129B2 (en) * | 2006-01-31 | 2010-08-31 | The Board Of Trustees Of The University Of Illinois | Method and apparatus for measurement of optical properties in tissue |
EP1983921B1 (en) | 2006-02-01 | 2016-05-25 | The General Hospital Corporation | Systems for providing electromagnetic radiation to at least one portion of a sample using conformal laser therapy procedures |
US9186066B2 (en) | 2006-02-01 | 2015-11-17 | The General Hospital Corporation | Apparatus for applying a plurality of electro-magnetic radiations to a sample |
EP1988825B1 (en) | 2006-02-08 | 2016-12-21 | The General Hospital Corporation | Arrangements and systems for obtaining information associated with an anatomical sample using optical microscopy |
EP2982929A1 (en) | 2006-02-24 | 2016-02-10 | The General Hospital Corporation | Methods and systems for performing angle-resolved fourier-domain optical coherence tomography |
US20070239033A1 (en) * | 2006-03-17 | 2007-10-11 | The General Hospital Corporation | Arrangement, method and computer-accessible medium for identifying characteristics of at least a portion of a blood vessel contained within a tissue using spectral domain low coherence interferometry |
EP2004041B1 (en) * | 2006-04-05 | 2013-11-06 | The General Hospital Corporation | Methods, arrangements and systems for polarization-sensitive optical frequency domain imaging of a sample |
JP2009536740A (en) | 2006-05-10 | 2009-10-15 | ザ ジェネラル ホスピタル コーポレイション | Process, configuration and system for providing frequency domain imaging of samples |
US7782464B2 (en) * | 2006-05-12 | 2010-08-24 | The General Hospital Corporation | Processes, arrangements and systems for providing a fiber layer thickness map based on optical coherence tomography images |
US8131348B2 (en) * | 2006-05-12 | 2012-03-06 | Northshore University Healthsystem | Systems, methods and apparatuses of elastic light scattering spectroscopy and low coherence enhanced backscattering spectroscopy |
WO2007133684A2 (en) * | 2006-05-12 | 2007-11-22 | Northwestern University | Systems, methods, and apparatuses of low-coherence enhanced backscattering spectroscopy |
CN101489471B (en) * | 2006-05-19 | 2014-08-27 | 北岸大学健康系统公司 | Apparatus for recognizing abnormal tissue using the detection of early increase in microvascular blood content |
US8774902B2 (en) * | 2006-06-01 | 2014-07-08 | Passive Imaging Medical Systems Engineering Ltd. (Pims) | Method of infrared thermography for earlier diagnosis of gastric colorectal and cervical cancer |
WO2007147058A2 (en) * | 2006-06-14 | 2007-12-21 | Cornova, Inc. | Method and apparatus for identifying and treating myocardial infarction |
CN101500472B (en) * | 2006-07-21 | 2014-02-12 | 昂科斯科公司 | Protective probe tip, particularly for use on fiber-optic probe used in endoscopic application |
US7800746B2 (en) * | 2006-08-11 | 2010-09-21 | Northwestern University | Method for identifying refractive-index fluctuations of a target |
US7920271B2 (en) | 2006-08-25 | 2011-04-05 | The General Hospital Corporation | Apparatus and methods for enhancing optical coherence tomography imaging using volumetric filtering techniques |
JP4276674B2 (en) * | 2006-10-13 | 2009-06-10 | 日信工業株式会社 | Brake hydraulic pressure control device for vehicle and manufacturing method of brake hydraulic pressure control device for vehicle |
US8838213B2 (en) | 2006-10-19 | 2014-09-16 | The General Hospital Corporation | Apparatus and method for obtaining and providing imaging information associated with at least one portion of a sample, and effecting such portion(s) |
US8498695B2 (en) | 2006-12-22 | 2013-07-30 | Novadaq Technologies Inc. | Imaging system with a single color image sensor for simultaneous fluorescence and color video endoscopy |
JP2010517080A (en) | 2007-01-19 | 2010-05-20 | ザ ジェネラル ホスピタル コーポレイション | Rotating disk reflection for fast wavelength scanning of dispersive broadband light |
JP5507258B2 (en) | 2007-01-19 | 2014-05-28 | ザ ジェネラル ホスピタル コーポレイション | Apparatus and method for controlling measurement depth in optical frequency domain imaging |
JP5208430B2 (en) * | 2007-01-31 | 2013-06-12 | オリンパス株式会社 | Fluorescence observation device for living tissue |
WO2008101003A1 (en) * | 2007-02-13 | 2008-08-21 | Cornova, Inc. | Biocompatible polymers, polymer tie-coats, methods of making and using the same, and products incorporating the polymers |
JP5558839B2 (en) | 2007-03-23 | 2014-07-23 | ザ ジェネラル ホスピタル コーポレイション | Method, arrangement and apparatus for utilizing a wavelength swept laser using angular scanning and dispersion procedures |
WO2008121844A1 (en) | 2007-03-30 | 2008-10-09 | The General Hospital Corporation | System and method providing intracoronary laser speckle imaging for the detection of vulnerable plaque |
US8045177B2 (en) | 2007-04-17 | 2011-10-25 | The General Hospital Corporation | Apparatus and methods for measuring vibrations using spectrally-encoded endoscopy |
WO2008137637A2 (en) | 2007-05-04 | 2008-11-13 | The General Hospital Corporation | Methods, arrangements and systems for obtaining information associated with a sample using brillouin microscopy |
WO2009011824A1 (en) * | 2007-07-13 | 2009-01-22 | The Brigham And Women's Hospital, Inc. | System and method for hernia mesh fixation |
EP2173254A2 (en) | 2007-07-31 | 2010-04-14 | The General Hospital Corporation | Systems and methods for providing beam scan patterns for high speed doppler optical frequency domain imaging |
US8040608B2 (en) | 2007-08-31 | 2011-10-18 | The General Hospital Corporation | System and method for self-interference fluorescence microscopy, and computer-accessible medium associated therewith |
WO2009036418A1 (en) * | 2007-09-13 | 2009-03-19 | Duke University | Apparatuses, systems, and methods for low-coherence interferometry (lci) |
EP2207469A4 (en) * | 2007-10-12 | 2012-07-11 | Gen Hospital Corp | Systems and processes for optical imaging of luminal anatomic structures |
WO2009059034A1 (en) | 2007-10-30 | 2009-05-07 | The General Hospital Corporation | System and method for cladding mode detection |
WO2009064746A2 (en) | 2007-11-12 | 2009-05-22 | Cornell University | Multi-path, multi-magnification, non-confocal fluorescence emission endoscopy apparatus and methods |
CA2711643A1 (en) * | 2008-01-08 | 2009-07-16 | Oncoscope, Inc. | Systems and methods for tissue examination, diagnostic, treatment, and/or monitoring |
US7751057B2 (en) | 2008-01-18 | 2010-07-06 | The Board Of Trustees Of The University Of Illinois | Magnetomotive optical coherence tomography |
US8983580B2 (en) | 2008-01-18 | 2015-03-17 | The Board Of Trustees Of The University Of Illinois | Low-coherence interferometry and optical coherence tomography for image-guided surgical treatment of solid tumors |
US8115934B2 (en) | 2008-01-18 | 2012-02-14 | The Board Of Trustees Of The University Of Illinois | Device and method for imaging the ear using optical coherence tomography |
US9332942B2 (en) | 2008-01-28 | 2016-05-10 | The General Hospital Corporation | Systems, processes and computer-accessible medium for providing hybrid flourescence and optical coherence tomography imaging |
US11123047B2 (en) | 2008-01-28 | 2021-09-21 | The General Hospital Corporation | Hybrid systems and methods for multi-modal acquisition of intravascular imaging data and counteracting the effects of signal absorption in blood |
US9952148B2 (en) * | 2008-02-19 | 2018-04-24 | Trustees Of Tufts College | Non-invasive optical characterization of biomaterial mineralization |
KR101517264B1 (en) | 2008-03-18 | 2015-05-04 | 노바다크 테크놀러지즈 인코포레이티드 | Imaging system for combined full-color reflectance and near-infrared imaging |
US8593619B2 (en) | 2008-05-07 | 2013-11-26 | The General Hospital Corporation | System, method and computer-accessible medium for tracking vessel motion during three-dimensional coronary artery microscopy |
US9042967B2 (en) | 2008-05-20 | 2015-05-26 | University Health Network | Device and method for wound imaging and monitoring |
JP2009283871A (en) * | 2008-05-26 | 2009-12-03 | Fujitsu Ltd | Rework soldering method and its apparatus |
EP2288948A4 (en) | 2008-06-20 | 2011-12-28 | Gen Hospital Corp | Fused fiber optic coupler arrangement and method for use thereof |
US9254089B2 (en) | 2008-07-14 | 2016-02-09 | The General Hospital Corporation | Apparatus and methods for facilitating at least partial overlap of dispersed ration on at least one sample |
JP2010025867A (en) * | 2008-07-23 | 2010-02-04 | Olympus Medical Systems Corp | Subject observation apparatus and subject observation method |
KR101109968B1 (en) | 2008-07-23 | 2012-02-17 | 올림푸스 메디칼 시스템즈 가부시키가이샤 | Subject observation apparatus and subject observation method |
US20100069760A1 (en) * | 2008-09-17 | 2010-03-18 | Cornova, Inc. | Methods and apparatus for analyzing and locally treating a body lumen |
US20100249607A1 (en) * | 2008-09-26 | 2010-09-30 | Massachusetts Institute Of Technology | Quantitative spectroscopic imaging |
US20100087741A1 (en) * | 2008-10-02 | 2010-04-08 | Novadaq Technologies Inc. | Method for identifying malignancies in barrett's esophagus using white light endoscopy |
ES2957932T3 (en) | 2008-12-10 | 2024-01-30 | Massachusetts Gen Hospital | Systems, apparatus and procedures for extending the image depth range of optical coherence tomography using optical subsampling |
US9885834B2 (en) | 2009-01-08 | 2018-02-06 | Northwestern University | Probe apparatus for measuring depth-limited properties with low-coherence enhanced backscattering |
CN102368947A (en) * | 2009-01-08 | 2012-03-07 | 美国生物光学公司 | Probe apparatus for recognizing abnormal tissue |
US9788728B2 (en) * | 2009-01-23 | 2017-10-17 | Beth Israel Deaconess Medical Center, Inc. | Endoscopic polarized multispectral light scattering scanning method |
US8097864B2 (en) | 2009-01-26 | 2012-01-17 | The General Hospital Corporation | System, method and computer-accessible medium for providing wide-field superresolution microscopy |
CA2749670A1 (en) | 2009-02-04 | 2010-08-12 | The General Hospital Corporation | Apparatus and method for utilization of a high-speed optical wavelength tuning source |
US9351642B2 (en) | 2009-03-12 | 2016-05-31 | The General Hospital Corporation | Non-contact optical system, computer-accessible medium and method for measurement at least one mechanical property of tissue using coherent speckle technique(s) |
US11490826B2 (en) | 2009-07-14 | 2022-11-08 | The General Hospital Corporation | Apparatus, systems and methods for measuring flow and pressure within a vessel |
CN102883658B (en) | 2009-11-19 | 2016-06-22 | 调节成像公司 | The method and apparatus analyzing turbid media for using structured lighting to detect via unit piece |
WO2011078882A1 (en) | 2009-12-24 | 2011-06-30 | Children's Medical Center Corporation | Capillary refill time diagnostic apparatus and methods |
US9274001B2 (en) | 2010-01-22 | 2016-03-01 | Duke University | Dual window processing schemes for spectroscopic optical coherence tomography (OCT) and fourier domain low coherence interferometry |
US9823127B2 (en) | 2010-01-22 | 2017-11-21 | Duke University | Systems and methods for deep spectroscopic imaging of biological samples with use of an interferometer and spectrometer |
WO2011109450A2 (en) | 2010-03-01 | 2011-09-09 | Colibri Heart Valve Llc | Percutaneously deliverable heart valve and methods associated therewith |
HUE052561T2 (en) | 2010-03-05 | 2021-05-28 | Massachusetts Gen Hospital | Apparatus for providing electro-magnetic radiation to a sample |
JP4918732B2 (en) * | 2010-03-05 | 2012-04-18 | 日本電気株式会社 | Light measuring apparatus and method |
US9069130B2 (en) | 2010-05-03 | 2015-06-30 | The General Hospital Corporation | Apparatus, method and system for generating optical radiation from biological gain media |
US11105686B2 (en) | 2010-05-10 | 2021-08-31 | University of Pittshurgh-Of the Commonwealth System of Higher Education | Spatial-domain low-coherence quantitative phase microscopy |
EP2575597B1 (en) | 2010-05-25 | 2022-05-04 | The General Hospital Corporation | Apparatus for providing optical imaging of structures and compositions |
JP5778762B2 (en) | 2010-05-25 | 2015-09-16 | ザ ジェネラル ホスピタル コーポレイション | Apparatus and method for spectral analysis of optical coherence tomography images |
US10285568B2 (en) | 2010-06-03 | 2019-05-14 | The General Hospital Corporation | Apparatus and method for devices for imaging structures in or at one or more luminal organs |
CA2806544C (en) | 2010-06-28 | 2016-08-23 | Colibri Heart Valve Llc | Method and apparatus for the endoluminal delivery of intravascular devices |
CN101922969A (en) * | 2010-08-30 | 2010-12-22 | 南通北极光自动控制技术有限公司 | Diffuse reflection spectrum analyzer of ultraviolet, visible and near-infrared on-line detection |
WO2012058381A2 (en) | 2010-10-27 | 2012-05-03 | The General Hospital Corporation | Apparatus, systems and methods for measuring blood pressure within at least one vessel |
CA3027755C (en) | 2010-12-14 | 2021-05-11 | Colibri Heart Valve Llc | Percutaneously deliverable heart valve including folded membrane cusps with integral leaflets |
US9451885B2 (en) * | 2010-12-22 | 2016-09-27 | University of Pittsburgh—of the Commonwealth System of Higher Education | Depth-selective fiber-optic probe |
JP2014507982A (en) | 2011-01-20 | 2014-04-03 | テル ハショマー メディカル リサーチ インフラストラクチャー アンド サーヴィシーズ リミテッド | Method and apparatus for providing information useful for diagnosis of gastrointestinal tract abnormalities |
GB2487940B (en) | 2011-02-09 | 2014-12-17 | Tel Hashomer Medical Res Infrastructure & Services Ltd | Methods and devices suitable for imaging blood-containing tissue |
KR20140000329A (en) | 2011-03-08 | 2014-01-02 | 노바다크 테크놀러지즈 인코포레이티드 | Full spectrum led illuminator |
US8721077B2 (en) | 2011-04-29 | 2014-05-13 | The General Hospital Corporation | Systems, methods and computer-readable medium for determining depth-resolved physical and/or optical properties of scattering media by analyzing measured data over a range of depths |
JP2014523536A (en) | 2011-07-19 | 2014-09-11 | ザ ジェネラル ホスピタル コーポレイション | System, method, apparatus and computer-accessible medium for providing polarization mode dispersion compensation in optical coherence tomography |
EP2748587B1 (en) | 2011-08-25 | 2021-01-13 | The General Hospital Corporation | Methods and arrangements for providing micro-optical coherence tomography procedures |
GB2495479B (en) * | 2011-10-03 | 2015-12-02 | Babiesfirst Ltd | Reflux probe |
US9341783B2 (en) | 2011-10-18 | 2016-05-17 | The General Hospital Corporation | Apparatus and methods for producing and/or providing recirculating optical delay(s) |
EP2790580A4 (en) | 2011-12-14 | 2015-08-12 | Univ Pennsylvania | Fiber optic flow and oxygenation monitoring using diffuse correlation and reflectance |
JP5876359B2 (en) * | 2012-03-30 | 2016-03-02 | シスメックス株式会社 | Canceration information providing method and canceration information providing apparatus |
WO2013148306A1 (en) | 2012-03-30 | 2013-10-03 | The General Hospital Corporation | Imaging system, method and distal attachment for multidirectional field of view endoscopy |
US11490797B2 (en) | 2012-05-21 | 2022-11-08 | The General Hospital Corporation | Apparatus, device and method for capsule microscopy |
US9415550B2 (en) | 2012-08-22 | 2016-08-16 | The General Hospital Corporation | System, method, and computer-accessible medium for fabrication miniature endoscope using soft lithography |
EP3401678B1 (en) | 2012-11-07 | 2020-04-08 | Modulated Imaging Inc. | Efficient modulated imaging |
JP2014123714A (en) * | 2012-11-20 | 2014-07-03 | Canon Inc | Solid-state image sensor and distance detector using the same |
WO2014120791A1 (en) | 2013-01-29 | 2014-08-07 | The General Hospital Corporation | Apparatus, systems and methods for providing information regarding the aortic valve |
WO2014121082A1 (en) | 2013-02-01 | 2014-08-07 | The General Hospital Corporation | Objective lens arrangement for confocal endomicroscopy |
WO2014144709A2 (en) | 2013-03-15 | 2014-09-18 | The General Hospital Corporation | Methods and systems for characterizing an object |
WO2014186353A1 (en) | 2013-05-13 | 2014-11-20 | The General Hospital Corporation | Detecting self-interefering fluorescence phase and amplitude |
EP3692887B1 (en) | 2013-07-19 | 2024-03-06 | The General Hospital Corporation | Imaging apparatus which utilizes multidirectional field of view endoscopy |
WO2015010133A1 (en) | 2013-07-19 | 2015-01-22 | The General Hospital Corporation | Determining eye motion by imaging retina. with feedback |
ES2893237T3 (en) | 2013-07-26 | 2022-02-08 | Massachusetts Gen Hospital | Apparatus with a laser arrangement using optical scattering for applications in optical coherence tomography in the Fourier domain |
WO2015105870A1 (en) | 2014-01-08 | 2015-07-16 | The General Hospital Corporation | Method and apparatus for microscopic imaging |
WO2015116986A2 (en) | 2014-01-31 | 2015-08-06 | The General Hospital Corporation | System and method for facilitating manual and/or automatic volumetric imaging with real-time tension or force feedback using a tethered imaging device |
US10228556B2 (en) | 2014-04-04 | 2019-03-12 | The General Hospital Corporation | Apparatus and method for controlling propagation and/or transmission of electromagnetic radiation in flexible waveguide(s) |
PT3171765T (en) | 2014-07-24 | 2021-10-27 | Univ Health Network | Collection and analysis of data for diagnostic purposes |
KR102513779B1 (en) | 2014-07-25 | 2023-03-24 | 더 제너럴 하스피탈 코포레이션 | Apparatus, devices and methods for in vivo imaging and diagnosis |
WO2016019235A1 (en) * | 2014-07-31 | 2016-02-04 | The University Of Akron | A smartphone endoscope system |
AU2016351730B2 (en) | 2015-11-13 | 2019-07-11 | Novadaq Technologies Inc. | Systems and methods for illumination and imaging of a target |
EP3408654B1 (en) | 2016-01-26 | 2022-08-03 | Stryker European Operations Limited | Fluorescence imaging system and method for fluorescence imaging |
USD916294S1 (en) | 2016-04-28 | 2021-04-13 | Stryker European Operations Limited | Illumination and imaging device |
US10869645B2 (en) | 2016-06-14 | 2020-12-22 | Stryker European Operations Limited | Methods and systems for adaptive imaging for low light signal enhancement in medical visualization |
EP4242743A3 (en) | 2017-02-10 | 2023-10-18 | Stryker European Operations Limited | Open-field handheld fluorescence imaging systems and methods |
WO2019051476A1 (en) | 2017-09-11 | 2019-03-14 | Incubar, LLC | Conduit vascular implant sealing device for reducing endoleak |
MX2021002723A (en) * | 2018-09-11 | 2021-05-12 | Koninklijke Philips Nv | System and method for measurement selection and probe guiding in a gingivitis detector. |
CN113117259B (en) * | 2019-12-30 | 2022-11-11 | 重庆融海超声医学工程研究中心有限公司 | Detection device |
Family Cites Families (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3675768A (en) * | 1969-03-17 | 1972-07-11 | Gildardo Legorreta Sanchez | Method and apparatus for classifying and segregating particles with electrical and optical means |
US4281931A (en) * | 1977-12-21 | 1981-08-04 | Machida Endoscope Co., Ltd. | Measuring apparatus comprising light optics utilizing cylindrical focusing glass fiber |
US4515165A (en) * | 1980-02-04 | 1985-05-07 | Energy Conversion Devices, Inc. | Apparatus and method for detecting tumors |
US4336809A (en) * | 1980-03-17 | 1982-06-29 | Burleigh Instruments, Inc. | Human and animal tissue photoradiation system and method |
JPS59105508A (en) * | 1982-12-08 | 1984-06-18 | Canon Inc | Measurement of whith interference film thickness |
US4948974A (en) * | 1984-06-25 | 1990-08-14 | Nelson Robert S | High resolution imaging apparatus and method for approximating scattering effects |
US4829184A (en) * | 1984-06-25 | 1989-05-09 | Nelson Robert S | Reflective, transmissive high resolution imaging apparatus |
US4718417A (en) * | 1985-03-22 | 1988-01-12 | Massachusetts Institute Of Technology | Visible fluorescence spectral diagnostic for laser angiosurgery |
US5106387A (en) * | 1985-03-22 | 1992-04-21 | Massachusetts Institute Of Technology | Method for spectroscopic diagnosis of tissue |
US5199431A (en) | 1985-03-22 | 1993-04-06 | Massachusetts Institute Of Technology | Optical needle for spectroscopic diagnosis |
US4655225A (en) * | 1985-04-18 | 1987-04-07 | Kurabo Industries Ltd. | Spectrophotometric method and apparatus for the non-invasive |
US4930516B1 (en) * | 1985-11-13 | 1998-08-04 | Laser Diagnostic Instr Inc | Method for detecting cancerous tissue using visible native luminescence |
US5284137A (en) * | 1988-07-26 | 1994-02-08 | Manfred Kessler | Process and device for the determination of local dye concentrations and of scattering parameters in animal and human tissues |
JPH0252205A (en) * | 1988-08-17 | 1990-02-21 | Dainippon Screen Mfg Co Ltd | Film thickness measuring method |
US5402778A (en) * | 1993-01-19 | 1995-04-04 | Nim Incorporated | Spectrophotometric examination of tissue of small dimension |
US5596987A (en) * | 1988-11-02 | 1997-01-28 | Noninvasive Technology, Inc. | Optical coupler for in vivo examination of biological tissue |
SE462408B (en) * | 1988-11-10 | 1990-06-18 | Pharmacia Ab | OPTICAL BIOSENSOR SYSTEM USING SURFACE MONITORING RESONSE FOR THE DETECTION OF A SPECIFIC BIOMOLIC CYCLE, TO CALIBRATE THE SENSOR DEVICE AND TO CORRECT FOUND BASELINE OPERATION IN THE SYSTEM |
US5386827A (en) * | 1993-03-30 | 1995-02-07 | Nim Incorporated | Quantitative and qualitative in vivo tissue examination using time resolved spectroscopy |
JP2637820B2 (en) * | 1989-03-27 | 1997-08-06 | オリンパス光学工業株式会社 | Optical film thickness measuring device |
US5421337A (en) * | 1989-04-14 | 1995-06-06 | Massachusetts Institute Of Technology | Spectral diagnosis of diseased tissue |
US5369496A (en) * | 1989-11-13 | 1994-11-29 | Research Foundation Of City College Of New York | Noninvasive method and apparatus for characterizing biological materials |
US5419321A (en) * | 1990-05-17 | 1995-05-30 | Johnson & Johnson Professional Products Limited | Non-invasive medical sensor |
DE69121633T2 (en) * | 1990-05-22 | 1997-01-16 | Japan Res Dev Corp | Method and apparatus for measuring spectral absorption in opaque material and method and apparatus for measuring a distribution of microscopic absorption |
US5168162A (en) * | 1991-02-04 | 1992-12-01 | Cornell Research Foundation, Inc. | Method of detecting the presence of anomalies in exfoliated cells using infrared spectroscopy |
US5303026A (en) * | 1991-02-26 | 1994-04-12 | The Regents Of The University Of California Los Alamos National Laboratory | Apparatus and method for spectroscopic analysis of scattering media |
US5280788A (en) | 1991-02-26 | 1994-01-25 | Massachusetts Institute Of Technology | Devices and methods for optical diagnosis of tissue |
US5203328A (en) * | 1991-07-17 | 1993-04-20 | Georgia Tech Research Corporation | Apparatus and methods for quantitatively measuring molecular changes in the ocular lens |
DE4129438A1 (en) * | 1991-09-04 | 1993-03-18 | Siemens Ag | MEASURING ARRANGEMENT FOR THE EXAMINATION OF AN OBJECT WITH VISIBLE, NIR OR IR LIGHT |
US5243615A (en) * | 1991-11-20 | 1993-09-07 | Laserscope | High-powered intracavity non-linear optic laser |
US5398685A (en) * | 1992-01-10 | 1995-03-21 | Wilk; Peter J. | Endoscopic diagnostic system and associated method |
US5317156A (en) * | 1992-01-29 | 1994-05-31 | Sri International | Diagnostic tests using near-infrared laser absorption spectroscopy |
US5452723A (en) * | 1992-07-24 | 1995-09-26 | Massachusetts Institute Of Technology | Calibrated spectrographic imaging |
US5460177A (en) * | 1993-05-07 | 1995-10-24 | Diasense, Inc. | Method for non-invasive measurement of concentration of analytes in blood using continuous spectrum radiation |
JP3310390B2 (en) * | 1993-06-10 | 2002-08-05 | 浜松ホトニクス株式会社 | Method and apparatus for measuring concentration of light absorbing substance in scattering medium |
US5596992A (en) * | 1993-06-30 | 1997-01-28 | Sandia Corporation | Multivariate classification of infrared spectra of cell and tissue samples |
JP3433508B2 (en) * | 1993-12-01 | 2003-08-04 | 浜松ホトニクス株式会社 | Scattering absorber measurement method and scattering absorber measuring device |
US5491344A (en) * | 1993-12-01 | 1996-02-13 | Tufts University | Method and system for examining the composition of a fluid or solid sample using fluorescence and/or absorption spectroscopy |
JPH07222712A (en) * | 1994-02-10 | 1995-08-22 | Olympus Optical Co Ltd | Fluorescent endoscope system |
US5560356A (en) * | 1994-02-23 | 1996-10-01 | Vitrophage, Inc. | Diagnostic system and method using an implanted reflective device |
US5625458A (en) * | 1994-11-10 | 1997-04-29 | Research Foundation Of City College Of New York | Method and system for imaging objects in turbid media using diffusive fermat photons |
US5919140A (en) * | 1995-02-21 | 1999-07-06 | Massachusetts Institute Of Technology | Optical imaging using time gated scattered light |
US5697373A (en) * | 1995-03-14 | 1997-12-16 | Board Of Regents, The University Of Texas System | Optical method and apparatus for the diagnosis of cervical precancers using raman and fluorescence spectroscopies |
US5699795A (en) * | 1995-03-31 | 1997-12-23 | Board Of Regents, The University Of Texas System | Optical probe for the detection of cervical neoplasia using fluorescence spectroscopy and apparatus incorporating same |
US5733739A (en) * | 1995-06-07 | 1998-03-31 | Inphocyte, Inc. | System and method for diagnosis of disease by infrared analysis of human tissues and cells |
US5813987A (en) * | 1995-08-01 | 1998-09-29 | Medispectra, Inc. | Spectral volume microprobe for analysis of materials |
US5713364A (en) * | 1995-08-01 | 1998-02-03 | Medispectra, Inc. | Spectral volume microprobe analysis of materials |
US5636633A (en) * | 1995-08-09 | 1997-06-10 | Rio Grande Medical Technologies, Inc. | Diffuse reflectance monitoring apparatus |
US5630423A (en) * | 1996-01-31 | 1997-05-20 | Wang; Lihong | Method of measuring tissue optical properties using an optical beam of oblique incidence and uses thereof |
US5931789A (en) * | 1996-03-18 | 1999-08-03 | The Research Foundation City College Of New York | Time-resolved diffusion tomographic 2D and 3D imaging in highly scattering turbid media |
US5994690A (en) | 1997-03-17 | 1999-11-30 | Kulkarni; Manish D. | Image enhancement in optical coherence tomography using deconvolution |
US6002480A (en) * | 1997-06-02 | 1999-12-14 | Izatt; Joseph A. | Depth-resolved spectroscopic optical coherence tomography |
US6091984A (en) | 1997-10-10 | 2000-07-18 | Massachusetts Institute Of Technology | Measuring tissue morphology |
-
1997
- 1997-10-10 US US08/948,734 patent/US6091984A/en not_active Expired - Lifetime
-
1998
- 1998-10-09 DE DE69825303T patent/DE69825303T2/en not_active Expired - Lifetime
- 1998-10-09 JP JP2000515487A patent/JP2001519190A/en active Pending
- 1998-10-09 WO PCT/US1998/021450 patent/WO1999018845A1/en active IP Right Grant
- 1998-10-09 AT AT98951038T patent/ATE271830T1/en not_active IP Right Cessation
- 1998-10-09 AU AU96932/98A patent/AU9693298A/en not_active Abandoned
- 1998-10-09 CN CN98810747.3A patent/CN1278153A/en active Pending
- 1998-10-09 EP EP98951038A patent/EP1021126B1/en not_active Expired - Lifetime
- 1998-10-09 CA CA002305898A patent/CA2305898A1/en not_active Abandoned
-
2000
- 2000-04-10 US US09/545,992 patent/US6922583B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US6091984A (en) | 2000-07-18 |
ATE271830T1 (en) | 2004-08-15 |
WO1999018845A1 (en) | 1999-04-22 |
AU9693298A (en) | 1999-05-03 |
EP1021126A1 (en) | 2000-07-26 |
EP1021126B1 (en) | 2004-07-28 |
CN1278153A (en) | 2000-12-27 |
DE69825303T2 (en) | 2005-07-28 |
DE69825303D1 (en) | 2004-09-02 |
US6922583B1 (en) | 2005-07-26 |
JP2001519190A (en) | 2001-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1021126B1 (en) | Method for measuring tissue morphology | |
JP4516217B2 (en) | Polarization scattering spectroscopy of tissue | |
JP4474050B2 (en) | Multi-mode optical tissue diagnosis system | |
RU2288636C2 (en) | Method and systems for detecting parameters and mapping of tissue lesions | |
CA2658811C (en) | Multi modal spectroscopy | |
US6507747B1 (en) | Method and apparatus for concomitant structural and biochemical characterization of tissue | |
US9788728B2 (en) | Endoscopic polarized multispectral light scattering scanning method | |
JP3923080B2 (en) | Optical fine probe and spectral analysis method of material | |
EP2194848A1 (en) | Systems and methods for spectral analysis of a tissue mass using an instrument, an optical probe, and a monte carlo or a diffusion algorithm | |
JP2009545737A (en) | In vivo cancer detection and / or diagnostic method using fluorescence-based DNA image cytometry | |
US20100249607A1 (en) | Quantitative spectroscopic imaging | |
Tunnell et al. | Diagnostic tissue spectroscopy and its applications to gastrointestinal endoscopy | |
AU781659B2 (en) | Method for measuring tissue morphology | |
Bigio et al. | Optical diagnostics based on elastic scattering: recent clinical demonstrations with the Los Alamos optical biopsy system | |
Fried et al. | Diagnostic Applications of Lasers | |
Alfano et al. | Lasers in cancer detection and diagnosis research: enabling characteristics with illustrative examples | |
Kim | Development of a real time trimodal spectroscopy diagnostic tool for Barrett's esophagus | |
Perelman et al. | Detection of early cancer and precancer with scattered light | |
Kashany et al. | Conference 8230: Biomedical Applications of Light Scattering VI | |
MXPA01002554A (en) | Multi-modal optical tissue diagnostic system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |